日本臨牀　82/増刊4　動脈・静脈の疾患2024（上）

出版社： 日本臨牀社
発行日： 2024-06-30
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 動脈・静脈の疾患2024（上）
電子書籍版： 2024-06-30 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

22,000 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

22,000 円(税込)

購入する

目次

  • 特集　動脈・静脈の疾患2024（上）
    　　　―最新の診断・治療動向―

    序文

    I 総論
    　1．動・静脈疾患の疫学
    　2．発症要因
    　　(1) 動脈硬化の危険因子
    　　　1) 高血圧
    　　　2) 糖尿病
    　　　3) 脂質異常症
    　　(2) 肥満と肥満症
    　　(3) 動脈硬化の危険因子
    　　　1) 喫煙
    　　　2) 飲酒と動脈硬化性疾患
    　　　3) 慢性腎臓病
    　　　4) 尿酸
    　　　5) 遺伝要因
    　　(4) 静脈血栓症の発症要因
    　　　1) 静脈血栓塞栓症の発症要因としての血液凝固能亢進
    　　　2) 血流うっ滞
    　　　3) 抗リン脂質抗体症候群
    　　　4) 妊娠関連静脈血栓塞栓症の発症要因について
    　　　5) 悪性腫瘍
    　　　6) 静脈血栓症の遺伝的要因

    II 動脈・静脈疾患の検査
    　1．動脈疾患の検査
    　　(1) 血液検査
    　　(2) 超音波検査
    　　(3) 動脈疾患のCT 検査
    　　(4) MR Angiography
    　　(5) 血管造影検査
    　　(6) 核医学検査
    　　(7) 血管機能検査
    　2．静脈疾患の検査
    　　(1) 血液検査
    　　(2) 超音波検査
    　　(3) CT 検査
    　　(4) MR venography の概要と進歩
    　　(5) 静脈の血管造影法(IVR における血管撮影)

    III 動脈・静脈疾患(四肢，体幹)
    　1．大動脈瘤
    　　(1) 胸部大動脈瘤
    　　　1) 病因と病態
    　　　2) 診断
    　　　3) 胸部大動脈瘤の治療
    　　(2) 腹部大動脈瘤
    　　　1) 腹部大動脈瘤の病因と病態
    　　　2) 腹部大動脈瘤の診断
    　　　3) 治療
    　2．大動脈解離
    　　(1) 病因と病態
    　　(2) 大動脈解離の診断
    　　(3) 大動脈解離の治療
    　3．頸動脈・椎骨動脈解離
    　　(1) 病因と病態
    　　(2) 頸動脈・椎骨動脈解離の診断
    　　(3) 治療
    　4．Marfan 症候群と類縁疾患
    　5．大動脈縮窄症
    　6．急性動脈閉塞症
    　　(1) 病因と病態
    　　(2) 診断
    　　(3) 治療
    　7．末梢動脈疾患
    　　(1) 病因と病態
    　　(2) 末梢動脈疾患(PAD)の診断
    　　(3) 末梢動脈疾患の治療
    　8．血栓性静脈炎
    　　(1) 病因と病態
    　　(2) 表在性血栓性静脈炎の診断
    　　(3) 治療
    　9．深部静脈血栓症
    　　(1) 病因と病態
    　　(2) 深部静脈血栓症の診断
    　　(3) 治療
    　10．下肢静脈瘤
    　　(1) 病因と病態
    　　(2) 診断
    　　(3) 治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 総論

P.12 掲載の参考文献
1) 木原朋未, 山岸良匡, 高田碧, ほか : 我が国の大動脈疾患の疫学と時代的推移. 日本循環器病予防学会誌 55 : 1-7, 2020.
 
2) Kihara T, Yamagishi K, Iso H, et al : Passive smoking and mortality from aortic dissection or aneurysm. Atherosclerosis 263 : 145-150, 2017.
 
3) Yang Y, Yamagishi K, Kihara T, et al : Smoking Cessation and Mortality from Aortic Dissection and Aneurysm : Findings from the Japan Collaborative Cohort (JACC) Study. J Atheroscler Thromb 30 : 348-363, 2023.
 
4) Shirakawa T, Yamagishi K, Yatsuya H, et al : Alcohol consumption and mortality from aortic disease among Japanese men : The Japan Collaborative Cohort study. Atherosclerosis 266 : 64-68, 2017.
 
5) Takada M, Yamagishi K, Tamakoshi A, et al : Body Mass Index and Mortality From Aortic Aneurysm and Dissection. J Atheroscler Thromb 28 : 338-348, 2021.
 
6) Takada M, Yamagishi K, Tamakoshi A, et al : Height and Mortality from Aortic Aneurysm and Dissection. J Atheroscler Thromb 29 : 1166-1175, 2022.
 
7) Tanimura T, Teramoto M, Tamakoshi A, et al : Association of Physical Activity with Aortic Disease in Japanese Men and Women : The Japan Collaborative Cohort Study. J Atheroscler Thromb 30 : 408-414, 2023.
 
8) Otaki Y, Watanabe T, Konta T, et al : Effect of Hypertension on Aortic Artery Disease-Related Mortality-3.8-Year Nationwide Community-Based Prospective Cohort Study-. Circ J 82 : 2776-2782, 2018.
 
9) Otaki Y, Watanabe T, Konta T, et al : Impact of hyperuricemia on mortality related to aortic diseases : a 3.8-year nationwide community-based cohort study. Sci Rep 10 : 14281, 2020.
 
10) Otaki Y, Watanabe T, Konta T, et al : Impact of Chronic Kidney Disease on Aortic Disease-related Mortality : A Four-year Community-Based Cohort Study. Intern Med 60 : 689-697, 2021.
 
11) Yamagishi K, Iso H, Shimazu T, et al : Fish intake and risk of mortality due to aortic dissection and aneurysm : A pooled analysis of the Japan cohort consortium. Clin Nutr 38 : 1678-1683, 2019.
 
12) Koba A, Yamagishi K, Sairenchi T, et al : Risk factors for mortality from aortic aneurysm and dissection : results from a 26-year follow-up of a community-based population. J Am Heart Assoc 12 : e027045, 2023.
 
13) Ohkuma T, Ninomiya T, Tomiyama H, et al : Ankle-brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population : An individual participant data meta-analysis. Atherosclerosis 275 : 141-148, 2018.
PubMed
14) Fujiwara T, Saitoh S, Takagi S, et al : Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan : Tanno-Sobetsu study. Atherosclerosis 177 : 83-88, 2004.
 
15) Ishida A, Miyagi M, Kinjo K, et al : Age- and sex-related effects on ankle-brachial index in a screened cohort of Japanese : the Okinawa Peripheral Arterial Disease Study (OPADS). Eur J Prev Cardiol 21 : 712-718, 2014.
 
16) Hozawa A, Ohmori K, Kuriyama S, et al : C-reactive protein and peripheral artery disease among Japanese elderly : the Tsurugaya Project. Hypertens Res 27 : 955-961, 2004.
 
17) Ohnishi H, Sawayama Y, Furusyo N, et al : Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis : the Kyushu and Okinawa Population Study (KOPS). J Atheroscler Thromb 17 : 751-758, 2010.
 
18) Fowkes FG, Rudan D, Rudan I, et al : Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010 : a systematic review and analysis. Lancet 382 : 1329-1340, 2013.
 
19) Ogata H, Kumata-Maeta C, Shishido K, et al : Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients. Clin J Am Soc Nephrol 5 : 2199-2206, 2010.
 
20) Ono K, Tsuchida A, Kawai H, et al : Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14 : 1591-1598, 2003.
 
21) Hoshino H, Itoh Y, Yamada S, et al : Prevalence and clinical features of asymptomatic peripheral artery disease in Japanese stroke patients. J Stroke Cerebrovasc Dis 22 : 255-259, 2013.
 
22) Imori Y, Akasaka T, Ochiai T, et al : Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. Am J Cardiol 113 : 30-35, 2014.
 
23) Maeda Y, Inoguchi T, Tsubouchi H, et al : High prevalence of peripheral arterial disease diagnosed by low ankle-brachial index in Japanese patients with diabetes : the Kyushu Prevention Study for Atherosclerosis. Diabetes Res Clin Pract 82 : 378-382, 2008.
 
24) Meissner MH, Wakefield TW, Ascher E, et al : Acute venous disease : venous thrombosis and venous trauma. J Vasc Surg 46 (Suppl) : 25S-53S, 2007.
 
25) Sakuma M, Nakamura M, Yamada N, et al : Venous thromboembolism : deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone. Circ J 73 : 305-309, 2009.
 
26) 星野俊一, 佐戸川弘之 : 深部静脈血栓症-本邦における静脈疾患に関するSurvey I. 静脈学 8 : 307-311, 1997.
 
27) 佐戸川弘之, 八巻隆, 岩田博英, ほか : 深部静脈血栓症症例と静脈血栓塞栓症の予防についてのアンケート調査-本邦における静脈疾患に関するサーベイ XIII-日本静脈学会静脈疾患サーベイ委員会報告. 静脈学 23 : 271-281, 2012.
 
28) 厚生労働科学研究費補助金難治性疾患克服研究事業「血液凝固異常症に関する調査研究班」 (研究代表者 : 池田康夫) 平成19年度総括・分担研究報告書, p16-17, 2008.
 
29) Ohira T, Iso H, Yamagishi K, et al : Fish Intake and Death From Pulmonary Embolisms Among Japanese Men and Women-The Japan Collaborative Cohort (JACC) Study. Circ J 82 : 2063-2070, 2018.
 
30) Shirakawa T, Iso H, Yamagishi K, et al : Watching Television and Risk of Mortality From Pulmonary Embolism Among Japanese Men and Women : The JACC Study (Japan Collaborative Cohort). Circulation 134 : 355-357, 2016.
 
P.20 掲載の参考文献
1) Mensah GA, Fuster V, Murray CJL, et al : Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol 82 : 2350-2473, 2023.
 
2) Bjorkegren JLM, Lusis AJ : Atherosclerosis : Recent developments. Cell 185 : 1630-1645, 2022.
 
3) Al-Mashhadi RH, Al-Mashhadi AL, Nasr ZP, et al : Local Pressure Drives Low-Density Lipoprotein Accumulation and Coronary Atherosclerosis in Hypertensive Minipigs. J Am Coll Cardiol 77 : 575-589, 2021.
 
4) 高血圧治療ガイドライン 2019 (JSH2019) (日本高血圧学会高血圧治療ガイドライン作成委員会編), 日本高血圧学会, ライフサイエンス出版, 2019.
 
5) Tatsumi Y, Ohkubo T : Hypertension with diabetes mellitus : significance from an epidemiological perspective for Japanese. Hypertens Res 40 : 795-806, 2017.
 
6) Sakima A, Satonaka H, Nishida N, et al : Optimal blood pressure targets for patients with hypertension : a systematic review and meta-analysis. Hypertens Res 42 : 483-495, 2019.
 
7) SPRINT Research Group ; Lewis CE, Fine LJ, Beddhu S, et al : Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 384 : 1921-1930, 2021.
 
8) Zhang W, Zhang S, Deng Y, et al : Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N Engl J Med 385 : 1268-1279, 2021.
 
9) Mancia G, Kreutz R, Brunstrom M, et al : 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension : Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 41 : 1874-2071, 2023.
 
10) Sawami K, Tanaka A, Node K : Recent understandings about hypertension management in type 2 diabetes : What are the roles of SGLT2 inhibitor, GLP-1 receptor agonist, and finerenone? Hypertens Res 46 : 1892-1899, 2023.
 
11) Ito S, Itoh H, Rakugi H, et al : Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study). Hypertension 75 : 51-58, 2020.
 
12) Ito S, Kashihara N, Shikata K, et al : Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN) : Phase 3 Randomized Controlled Clinical Trial. Clin J Am Soc Nephrol 15 : 1715-1727, 2020.
 
13) Epstein M, Kovesdy CP, Clase CM, et al : Aldosterone, Mineralocorticoid Receptor Activation, and CKD : A Review of Evolving Treatment Paradigms. Am J Kidney Dis 80 : 658-666, 2022.
 
14) Yamamoto K, Rakugi H : Angiotensin receptor-neprilysin inhibitors : Comprehensive review and implications in hypertension treatment. Hypertens Res 44 : 1239-1250, 2021.
 
15) Chua SK, Lai WT, Chen LC, et al : The Antihypertensive Effects and Safety of LCZ696 in Patients with Hypertension : A Systemic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med 10 : 2824, 2021.
 
P.24 掲載の参考文献
1) Stamler J, Vaccaro O, Neaton JD, et al : Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 : 434-444, 1993.
 
2) Sone H, Tanaka S, Tanaka S, et al : Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes : subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab 96 : 3448-3456, 2011.
 
3) 藤島正敏, 篠原規恭, 清原裕, ほか : 心血管病発症のリスクとしての耐糖能異常-久山町研究-. 糖尿病 41 (Suppl 2) : A45-A47, 1998.
 
4) Tominaga M, Eguchi H, Manaka H, et al : Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 : 920-924, 1999.
 
5) Turner RC, Millns H, Neil HA, et al : Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus : United Kingdom Prospective Diabetes Study (UKPDS : 23). BMJ 316 : 823-828, 1998.
 
6) Valensi P, Paries J, Brulport-Cerisier V, et al : Predictive value of silent myocardial ischemia for cardiac events in diabetic patients : influence of age in a French multicenter study. Diabetes Care 28 : 2722-2727, 2005.
 
7) Murabito JM, D'Agostino RB, Silbershatz H, et al : Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 96 : 44-49, 1997.
 
8) Selvin E, Marinopoulos S, Berkenblit G, et al : Meta-analysis : glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 : 421-431, 2004.
 
9) Action to Control Cardiovascular Risk in Diabetes Study Group ; Gerstein HC, Miller ME, Byington RP, et al : Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 : 2545-2559, 2008.
 
10) ADVANCE Collaborative Group ; Patel A, MacMahon S, Chalmers J, et al : Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 : 2560-2572, 2008.
 
11) Duckworth W, Abraira C, Moritz T, et al : Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 : 129-139, 2009.
 
12) Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group : Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy : the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290 : 2159-2167, 2003.
 
13) Rosenstock J, Wysham C, Frias JP, et al : Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1) : a double-blind, randomised, phase 3 trial. Lancet 398 : 143-155, 2021.
 
14) UK Prospective Diabetes Study Group : Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes : UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317 : 703-713, 1998.
 
15) Gaede P, Lund-Andersen H, Parving HH, et al : Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358 : 580-591, 2008.
 
P.30 掲載の参考文献
1) Cholesterol Treatment Trialists' (CTT) Collaboration ; Baigent C, Blackwell L, Emberson J, et al : Efficacy and safety of more intensive lowering of LDL cholesterol : a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376 : 1670-1681, 2010.
 
2) Bjorkegren JLM, Lusis AJ : Atherosclerosis : Recent developments. Cell 185 : 1630-1645, 2022.
 
3) Imano H, Noda H, Kitamura A, et al : Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women : the Circulatory Risk in Communities Study (CIRCS). Prev Med 52 : 381-386, 2011.
 
4) Nakamura H, Arakawa K, Itakura H, et al : Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study) : a prospective randomised controlled trial. Lancet 368 : 1155-1163, 2006.
PubMed
5) Yoshida H, Kisugi R : Mechanisms of LDL oxidation. Clin Chim Acta 411 : 1875-1882, 2010.
 
6) Nishikura T, Koba S, Yokota Y, et al : Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease. J Atheroscler Thromb 21 : 755-767, 2014.
 
7) Han YH, Onufer EJ, Huang LH, et al : Enterically derived high-density lipoprotein restrains liver injury through the portal vein. Science 373 : eabe6729, 2021.
 
8) Thomas DG, Wei Y, Tall AR : Lipid and metabolic syndrome traits in coronary artery disease : a Mendelian randomization study. J Lipid Res 62 : 100044, 2021.
 
9) Okamura T, Kokubo Y, Watanabe M, et al : Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study : The Suita study. Atherosclerosis 203 : 587-592, 2009.
 
10) Okamura T, Kokubo Y, Watanabe M, et al : Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort : the Suita study. Atherosclerosis 209 : 290-294, 2010.
 
11) Miller M, Cannon CP, Murphy SA, et al : Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 51 : 724-730, 2008.
 
12) Yamashita S, Arai H, Bujo H, et al : Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE). J Atheroscler Thromb 28 : 103-123, 2021.
 
13) Libby P : The changing landscape of atherosclerosis. Nature 592 : 524-533, 2021.
 
14) Varbo A, Benn M, Tybjarg-Hansen A, et al : Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation 128 : 1298-1309, 2013.
 
15) Willeit P, Ridker PM, Nestel PJ, et al : Baseline and on-statin treatment lipoprotein (a) levels for prediction of cardiovascular events : individual patient-data meta-analysis of statin outcome trials. Lancet 392 : 1311-1320, 2018.
 
P.37 掲載の参考文献
1) Uema T, Millman JF, Okamoto S, et al : Profile of gut microbiota and serum metabolites associated with metabolic syndrome in a remote island most afflicted by obesity in Japan. Sci Rep 12 : 17292, 2022.
 
2) 肥満症診療ガイドライン 2022 (日本肥満学会編), ライフサイエンス出版, 2022.
 
3) 吉池信男, 西信雄, 松島松翠, ほか : Body Mass Indexに基づく肥満の程度と糖尿病, 高血圧, 高脂血症の危険因子との関連-多施設共同研究による疫学的検討. 肥満研究 6 : 4-17, 2000.
 
4) Batsis JA, Villareal DT : Sarcopenic obesity in older adults : aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 14 : 513-537, 2018.
 
5) Costanzo P, Cleland JGF, Pellicori P, et al : The obesity paradox in type 2 diabetes mellitus : relationship of body mass index to prognosis : a cohort study. Ann Intern Med 162 : 610-618, 2015.
 
6) 益崎裕章, 島袋充生 : 肥満症とメタボリックシンドローム : 最近の知見と展望. 日本内科学会雑誌 106 : 477-483, 2017.
 
7) メタボリックシンドローム診断基準検討委員会 : メタボリックシンドロームの定義と診断基準. 日本内科学会雑誌 94 : 794-809, 2005.
 
8) 益崎裕章 : 肥満症. 今日の治療指針 [2023年版] 第65巻 (福井次矢, 高木誠, 小室一成総編集), p743-744, 医学書院, 2023.
 
P.45 掲載の参考文献
1) Klein LW, Gopalakrishnan M : The Correlation Between Cigarette Smoking and Other Risk Factors With Coronary Stenosis Composition. J Invasive Cardiol 27 : 359-361, 2015.
 
2) Munzel T, Hahad O, Kuntic M, et al : Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J 41 : 4057-4070, 2020.
 
3) Doyle JT, Dawber TR, Kannel WB, et al : Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med 266 : 796-801, 1962.
PubMed
4) Teo KK, Ounpuu S, Hawken S, et al : Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study : a case-control study. Lancet 368 : 647-658, 2006.
 
5) Zhang YJ, Iqbal J, van Klaveren D, et al : Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG : the SYNTAX trial at 5-year follow-up. J Am Coll Cardiol 65 : 1107-1115, 2015.
 
6) Yamaguchi Y, Matsuno S, Kagota S, et al : Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin. Atherosclerosis 172 : 259-265, 2004.
 
7) Daiber A, Steven S, Weber A, et al : Targeting vascular (endothelial) dysfunction. Br J Pharmacol 174 : 1591-1619, 2017.
 
8) Forstermann U, Xia N, Li H : Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circ Res 120 : 713-735, 2017.
 
9) Heitzer T, Just H, Munzel T : Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94 : 6-9, 1996.
 
10) Heitzer T, Brockhoff C, Mayer B, et al : Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res 86 : E36-E41, 2000.
 
11) Bohm F, Pernow J : The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76 : 8-18, 2007.
 
12) Hahad O, Arnold N, Prochaska JH, et al : Cigarette Smoking Is Related to Endothelial Dysfunction of Resistance, but Not Conduit Arteries in the General Population-Results From the Gutenberg Health Study. Front Cardiovasc Med 8 : 674622, 2021.
 
13) Celermajer DS, Sorensen KE, Georgakopoulos D, et al : Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88 : 2149-2155, 1993.
 
14) Zeiher AM, Schachinger V, Minners J : Long-term cigarette smoking impairs endotheliumdependent coronary arterial vasodilator function. Circulation 92 : 1094-1100, 1995.
 
15) Raitakari OT, Adams MR, McCredie RJ, et al : Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 130 : 578-581, 1999.
 
16) Freedman DS, Srinivasan SR, Shear CL, et al : Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood : the Bogalusa Heart Study. Am J Epidemiol 124 : 207-219, 1986.
 
17) Bolorunduro O, Cushman C, Kapoor D, et al : Comparison of Coronary Atherosclerotic Plaque Burden and Composition of Culprit Lesions Between Cigarette Smokers and Non-Smokers by In Vivo Virtual Histology Intravascular Ultrasound. J Invasive Cardiol 27 : 354-358, 2015.
 
18) McEvoy JW, Blaha MJ, DeFilippis AP, et al : Cigarette smoking and cardiovascular events : role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 35 : 700-709, 2015.
 
19) Cavusoglu Y, Timuralp B, Us T, et al : Cigarette smoking increases plasma concentrations of vascular cell adhesion molecule-1 in patients with coronary artery disease. Angiology 55 : 397-402, 2004.
 
20) Barua RS, Ambrose JA : Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol 33 : 1460-1467, 2013.
 
21) Carnevale R, Sciarretta S, Violi F, et al : Acute Impact of Tobacco vs Electronic Cigarette Smoking on Oxidative Stress and Vascular Function. Chest 150 : 606-612, 2016.
 
22) Skotsimara G, Antonopoulos AS, Oikonomou E, et al : Cardiovascular effects of electronic cigarettes : A systematic review and meta-analysis. Eur J Prev Cardiol 26 : 1219-1228, 2019.
 
23) Ding N, Sang Y, Chen J, et al : Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases. J Am Coll Cardiol 74 : 498-507, 2019.
 
P.52 掲載の参考文献
1) Corrao G, Rubbiati L, Bagnardi V, et al : Alcohol and coronary heart disease : a meta-analysis. Addiction 95 : 1505-1523, 2000.
 
2) Ikehara S, Iso H, Toyoshima H, et al : Alcohol consumption and mortality from stroke and coronary heart disease among Japanese men and women : the Japan collaborative cohort study. Stroke 39 : 2936-2942, 2008.
 
3) Kitamura A, Iso H, Sankai T, et al : Alcohol intake and premature coronary heart disease in urban Japanese men. Am J Epidemiol 147 : 59-65, 1998.
 
4) Hisamatsu T, Miura K, Tabara Y, et al : Alcohol consumption and subclinical and clinical coronary heart disease : a Mendelian randomization analysis. Eur J Prev Cardiol 29 : 2006-2014, 2022.
 
5) Reynolds K, Lewis B, Nolen JD, et al : Alcohol consumption and risk of stroke : a meta-analysis. JAMA 289 : 579-588, 2003.
 
6) Larsson SC, Wallin A, Wolk A, et al : Differing association of alcohol consumption with different stroke types : a systematic review and meta-analysis. BMC Med 14 : 178, 2016.
 
7) Iso H, Baba S, Mannami T, et al : Alcohol consumption and risk of stroke among middle-aged men : the JPHC Study Cohort I. Stroke 35 : 1124-1129, 2004.
 
8) Kiyohara Y, Kato I, Iwamoto H, et al : The impact of alcohol and hypertension on stroke incidence in a general Japanese population. The Hisayama Study. Stroke 26 : 368-372, 1995.
 
9) Wood AM, Kaptoge S, Butterworth AS, et al : Risk thresholds for alcohol consumption : combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391 : 1513-1523, 2018.
 
10) Marmot MG, Elliott P, Shipley MJ, et al : Alcohol and blood pressure : the INTERSALT study. BMJ 308 : 1263-1267, 1994.
 
11) Matsumoto-Yamauchi H, Kondo K, Miura K, et al : Relationships of Alcohol Consumption with Coronary Risk Factors and Macro- and Micro-Nutrient Intake in Japanese People : The INTERLIPID Study. J Nutr Sci Vitaminol (Tokyo) 67 : 28-38, 2021.
 
12) Mostofsky E, Mukamal KJ, Giovannucci EL, et al : Key Findings on Alcohol Consumption and a Variety of Health Outcomes From the Nurses' Health Study. Am J Public Health 106 : 1586-1591, 2016.
 
13) Hirata A, Sugiyama D, Watanabe M, et al : Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals : The EPOCH-JAPAN study. J Clin Lipidol 12 : 674-684.e5, 2018.
 
14) 厚生労働省 : 健康に配慮した飲酒に関するガイドライン, 2024.
 
P.58 掲載の参考文献
1) Go AS, Chertow GM, Fan D, et al : Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 : 1296-1305, 2004.
 
2) Ninomiya T, Kiyohara Y, Kubo M, et al : Chronic kidney disease and cardiovascular disease in a general Japanese population : the Hisayama Study. Kidney Int 68 : 228-236, 2005.
 
3) Nakano T, Ninomiya T, Sumiyoshi S, et al : Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders : the Hisayama study. Am J Kidney Dis 55 : 21-30, 2010.
 
4) Kashiyama K, Sonoda S, Muraoka Y, et al : Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease : intravascular ultrasound and integrated backscatter intravascular ultrasound study. Int J Cardiovasc Imaging 31 : 935-945, 2015.
 
5) Poznyak AV, Sadykhov NK, Kartuesov AG, et al : Atherosclerosis Specific Features in Chronic Kidney Disease (CKD). Biomedicines 10 : 2094, 2022.
 
6) Yan Z, Shao T : Chronic Inflammation in Chronic Kidney Disease. Nephron 148 : 143-151, 2024.
 
7) Kuro-o M : Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression. Curr Opin Nephrol Hypertens 32 : 344-351, 2023.
 
8) Ogata H, Sugawara H, Yamamoto M, et al : Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease. J Atheroscler Thromb 31 : 1-14, 2024.
 
9) Zhou C, He Q, Gan H, et al : Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans. Kidney Int 99 : 1342-1353, 2021.
 
10) Hioki H, Miyashita Y, Shiraki T, et al : Impact of deteriorated calcium-phosphate homeostasis on amputation-free survival after endovascular revascularization in patients with critical limb ischemia on hemodialysis. Vasc Med 21 : 137-143, 2016.
 
11) Shimamoto S, Yamada S, Hiyamuta H, et al : Association of serum phosphate concentration with the incidence of intervention for peripheral artery disease in patients undergoing hemodialysis : 10-year outcomes of the Q-Cohort Study. Atherosclerosis 304 : 22-29, 2020.
 
12) エビデンスに基づくCKD診療ガイドライン 2023 (日本腎臓学会編), 東京医学社, 2023.
 
13) Cheung AK, Rahman M, Reboussin DM, et al : Effects of Intensive BP Control in CKD. J Am Soc Nephrol 28 : 2812-2823, 2017.
 
14) Bansal N, McCulloch CE, Lin F, et al : Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int 90 : 1348-1356, 2016.
 
15) Berl T, Hunsicker LG, Lewis JB, et al : Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 16 : 2170-2179, 2005.
 
16) Yano Y, Rakugi H, Bakris GL, et al : On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension. Hypertension 69 : 220-227, 2017.
 
17) Marso SP, Daniels GH, Brown-Frandsen K, et al : Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 375 : 311-322, 2016.
 
18) Marso SP, Bain SC, Consoli A, et al : Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 375 : 1834-1844, 2016.
 
19) Zinman B, Wanner C, Lachin JM, et al : Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 373 : 2117-2128, 2015.
PubMed
20) Neal B, Perkovic V, Mahaffey KW, et al : Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. N Engl J Med 377 : 644-657, 2017.
 
21) Wiviott SD, Raz I, Bonaca MP, et al : Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med 380 : 347-357, 2019.
 
22) Perkovic V, Jardine MJ, Neal B, et al : Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med 380 : 2295-2306, 2019.
PubMed
23) Heerspink HJL, Stefansson BV, Correa-Rotter R, et al : Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 383 : 1436-1446, 2020.
PubMed
24) The EMPA-KIDNEY Collaborative Group ; Herrington WG, Staplin N, Wanner C, et al : Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 388 : 117-127, 2023.
 
25) Mukhopadhyay P, Sanyal D, Chatterjee P, et al : SGLT2 Inhibitors : Effect on Myocardial Infarction and Stroke in Type 2 Diabetes. J Clin Endocrinol Metab 108 : 2134-2140, 2023.
 
26) Kim JS, Lee G, Park KI, et al : Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention : A Systematic Review and Network Meta-Analysis. Diabetes Metab J 48 : 312-320, 2024.
 
27) Tsai PC, Chuang WJ, Ko AM, et al : Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke : a meta-analysis of randomized controlled trials. Cardiovasc Diabetol 22 : 57, 2023.
 
28) Rahman H, Khan SU, Lone AN, et al : Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease : A Meta-Analysis of Randomized Trials and Systematic Review. J Am Heart Assoc 12 : e030578, 2023.
 
29) Huang X, Dannya E, Liu X, et al : Effect of sodium-glucose cotransporter-2 inhibitors on myocardial infarction incidence : A systematic review and meta-analysis of randomized controlled trials and cohort studies. Diabetes Obes Metab 26 : 1040-1049, 2024.
 
30) Nakamura H, Mizuno K, Ohashi Y, et al : Pravastatin and cardiovascular risk in moderate chronic kidney disease. Atherosclerosis 206 : 512-517, 2009.
 
31) Wanner C, Krane V, Marz W, et al : Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 : 238-248, 2005.
 
32) Fellstrom BC, Jardine AG, Schmieder RE, et al : Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 : 1395-1407, 2009.
 
33) Baigent C, Landray MJ, Reith C, et al : The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection) : a randomised placebo-controlled trial. Lancet 377 : 2181-2192, 2011.
 
34) Silbernagel G, Fauler G, Genser B, et al : Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients. J Am Coll Cardiol 65 : 2291-2298, 2015.
 
35) Massy ZA, Merkling T, Wagner S, et al : Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients. Clin J Am Soc Nephrol 17 : 546-554, 2022.
 
36) Okute Y, Shoji T, Shimomura N, et al : Serum phosphate as an independent factor associated with cholesterol metabolism in patients undergoing hemodialysis : a cross-sectional analysis of the DREAM cohort. Nephrol Dial Transplant 38 : 1002-1008, 2023.
 
37) 日本透析医学会 : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 日本透析医学会雑誌 45 : 301-356, 2012.
 
38) Kidney Disease : Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group : KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011) 7 : 1-59, 2017.
 
39) Isaka Y, Hamano T, Fujii H, et al : Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients. J Am Soc Nephrol 32 : 723-735, 2021.
 
40) Ogata H, Fukagawa M, Hirakata H, et al : Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis : The LANDMARK Randomized Clinical Trial. JAMA 325 : 1946-1954, 2021.
 
41) Heerspink HJL, Parving HH, Andress DL, et al : Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) : a double-blind, randomised, placebo-controlled trial. Lancet 393 : 1937-1947, 2019.
 
42) Tuttle KR, Hauske SJ, Canziani ME, et al : Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease : a randomised, controlled, phase 2 trial. Lancet 403 : 379-390, 2024.
 
P.65 掲載の参考文献
1) Furuhashi M : New insights into purine metabolism in metabolic diseases : role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab 319 : E827-E834, 2020.
 
2) Rothschild BM, Tanke D, Carpenter K : Tyrannosaurs suffered from gout. Nature 387 : 357, 1997.
 
3) Mori K, Furuhashi M, Tanaka M, et al : U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects : BOREAS-CKD2. Hypertens Res 44 : 107-116, 2021.
 
4) Jansen H, Samani NJ, Schunkert H : Mendelian randomization studies in coronary artery disease. Eur Heart J 35 : 1917-1924, 2014.
 
5) Li X, Meng X, Timofeeva M, et al : Serum uric acid levels and multiple health outcomes : umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ 357 : j2376, 2017.
 
6) Furuhashi M, Matsumoto M, Tanaka M, et al : Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population. Circ J 82 : 1892-1899, 2018.
 
7) Furuhashi M, Matsumoto M, Murase T, et al : Independent links between plasma xanthine oxidoreductase activity and levels of adipokines. J Diabetes Investig 10 : 1059-1067, 2019.
 
8) Furuhashi M, Koyama M, Matsumoto M, et al : Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight. Endocr J 66 : 777-786, 2019.
 
9) Furuhashi M, Mori K, Tanaka M, et al : Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid. Endocr J 65 : 1083-1092, 2018.
 
10) Furuhashi M, Koyama M, Higashiura Y, et al : Differential regulation of hypoxanthine and xanthine by obesity in a general population. J Diabetes Investig 11 : 878-887, 2020.
 
11) Johnson TA, Kamatani N, Kuwabara M : Xanthine Oxidase Inhibitor Withdrawal Syndrome? Comment on the Article by Choi et al. Arthritis Rheumatol 71 : 1966-1967, 2019.
 
P.69 掲載の参考文献
1) Wahlgren CM, Magnusson PK : Genetic influences on peripheral arterial disease in a twin population. Arterioscler Thromb Vasc Biol 31 : 678-682, 2011.
 
2) Khaleghi M, Isseh IN, Bailey KR, et al : Family history as a risk factor for peripheral arterial disease. Am J Cardiol 114 : 928-932, 2014.
 
3) Gudmundsson G, Matthiasson SE, Arason H, et al : Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am J Hum Genet 70 : 586-592, 2002.
 
4) Kullo IJ, Turner ST, Kardia SL, et al : A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study. Atherosclerosis 187 : 433-438, 2006.
 
5) Tobacco and Genetics Consortium : Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42 : 441-447, 2010.
 
6) Vujkovic M, Keaton JM, Lynch JA, et al : Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet 52 : 680-691, 2020.
 
7) Hellwege JN, Velez Edwards DR, Giri A, et al : Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program. Nat Commun 10 : 3842, 2019.
 
8) Ehret GB, Ferreira T, Chasman DI, et al : The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet 48 : 1171-1184, 2016.
 
9) Willer CJ, Schmidt EM, Sengupta S, et al : Discovery and refinement of loci associated with lipid levels. Nat Genet 45 : 1274-1283, 2013.
 
10) Teslovich TM, Musunuru K, Smith AV, et al : Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466 : 707-713, 2010.
 
11) Thorgeirsson TE, Geller F, Sulem P, et al : A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452 : 638-642, 2008.
 
12) Helgadottir A, Thorleifsson G, Magnusson KP, et al : The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40 : 217-224, 2008.
 
13) Gretarsdottir S, Baas AF, Thorleifsson G, et al : Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 42 : 692-697, 2010.
 
14) Koriyama H, Nakagami H, Katsuya T, et al : Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population. J Atheroscler Thromb 17 : 1054-1062, 2010.
 
15) Matsukura M, Ozaki K, Takahashi A, et al : Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese Population. PLoS One 10 : e0139262, 2015.
 
16) Murabito JM, White CC, Kavousi M, et al : Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 5 : 100-112, 2012.
 
17) Burgess S, Butterworth A, Thompson SG : Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37 : 658-665, 2013.
 
18) Dikilitas O, Satterfield BA, Kullo IJ : Risk Factors for Polyvascular Involvement in Patients With Peripheral Artery Disease : A Mendelian Randomization Study. J Am Heart Assoc 9 : e017740, 2020.
 
19) Sabater-Lleal M, Huffman JE, de Vries PS, et al : Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels. Circulation 139 : 620-635, 2019.
 
20) Kettunen J, Demirkan A, Wurtz P, et al : Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun 7 : 11122, 2016.
 
21) Levin MG, Zuber V, Walker VM, et al : Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease. Circulation 144 : 353-364, 2021.
 
22) Breitling LP : Current genetics and epigenetics of smoking/tobacco-related cardiovascular disease. Arterioscler Thromb Vasc Biol 33 : 1468-1472, 2013.
 
23) Ntalla I, Kanoni S, Zeng L, et al : Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases. J Am Coll Cardiol 73 : 2932-2942, 2019.
 
24) Wang F, Ghanzouri I, Leeper NJ, et al : Development of a polygenic risk score to improve detection of peripheral artery disease. Vasc Med 27 : 219-227, 2022.
 
P.75 掲載の参考文献
1) 日本循環器学会. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版), 2018. [https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf] (2024年5月閲覧)
 
2) Grover SP, Mackman N : Intrinsic Pathway of Coagulation and Thrombosis. Arterioscler Thromb Vasc Biol 39 : 331-338, 2019.
 
3) Mackman N, Tilley RE, Key NS : Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 27 : 1687-1693, 2007.
 
4) Rezaie AR, Giri H : Anticoagulant and signaling functions of antithrombin. J Thromb Haemost 18 : 3142-3153, 2020.
 
5) Mosnier LO, Zlokovic BV, Griffin JH : The cytoprotective protein C pathway. Blood 109 : 3161-3172, 2007.
 
6) Miyata T, Sato Y, Ishikawa J, et al : Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis. Thromb Res 124 : 14-18, 2009.
 
7) Bertina RM, Koeleman BP, Koster T, et al : Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 : 64-67, 1994.
PubMed
8) Nogami K, Shinozawa K, Ogiwara K, et al : Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden. Blood 123 : 2420-2428, 2014.
 
9) Miyawaki Y, Suzuki A, Fujita J, et al : Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 366 : 2390-2396, 2012.
 
10) Patnaik MM, Moll S : Inherited antithrombin deficiency : a review. Haemophilia 14 : 1229-1239, 2008.
 
11) Sakata T, Okamoto A, Mannami T, et al : Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese. J Thromb Haemost 2 : 528-530, 2004.
PubMed
12) Dykes AC, Walker ID, McMahon AD, et al : A study of Protein S antigen levels in 3788 healthy volunteers : influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 113 : 636-641, 2001.
 
13) Sakata T, Okamoto A, Mannami T, et al : Prevalence of protein S deficiency in the Japanese general population : the Suita Study. J Thromb Haemost 2 : 1012-1013, 2004.
 
14) Hayashi T, Nishioka J, Shigekiyo T, et al : Protein S Tokushima : abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 83 : 683-690, 1994.
 
15) Varki A : Trousseau's syndrome : multiple definitions and multiple mechanisms. Blood 110 : 1723-1729, 2007.
 
P.83 掲載の参考文献
1) 小川智弘 : 静脈機能生理 (弁, トーヌス, 筋ポンプ). 新臨床静脈学 (日本静脈学会編), p17-20, メジカルビュー社, 2019.
 
2) Takahashi M, Yamashita A, Moriguchi-Goto S, et al : Critical role of von Willebrand factor and platelet interaction in venous thromboembolism. Histol Histopathol 24 : 1391-1398, 2009.
 
3) Furukoji E, Gi T, Yamashita A, et al : CD163 macrophage and erythrocyte contents in aspirated deep vein thrombus are associated with the time after onset : a pilot study. Thromb J 14 : 46, 2016.
 
4) Gi T, Kuroiwa Y, Yamashita A, et al : High Signal Intensity on Diffusion-Weighted Images Reflects Acute Phase of Deep Vein Thrombus. Thromb Haemost 120 : 1463-1473, 2020.
 
5) Yamashita A, Asada Y : Underlying mechanisms of thrombus formation/growth in atherothrombosis and deep vein thrombosis. Pathol Int 73 : 65-80, 2023.
 
6) Hisada Y, Mackman N : Mechanisms of cancer-associated thrombosis. Res Pract Thromb Haemost 7 : 100123, 2023.
 
7) Gi T, Kuwahara A, Yamashita A, et al : Histopathological Features of Cancer-Associated Venous Thromboembolism : Presence of Intrathrombus Cancer Cells and Prothrombotic Factors. Arterioscler Thromb Vasc Biol 43 : 146-159, 2023.
 
8) Key NS : Epidemiologic and clinical data linking factors XI and XII to thrombosis. Hematology Am Soc Hematol Educ Program 2014 : 66-70, 2014.
 
9) Brooks EG, Trotman W, Wadsworth MP, et al : Valves of the deep venous system : an overlooked risk factor. Blood 114 : 1276-1279, 2009.
 
10) Rajeeva Pandian NK, Walther BK, Suresh R, et al : Microengineered human vein-chip recreates venous valve architecture and its contribution to thrombosis. Small 16 : e2003401, 2020.
 
11) von Bruhl ML, Stark K, Steinhart A, et al : Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209 : 819-835, 2012.
PubMed
12) Diaz JA, Saha P, Cooley B, et al : Choosing a Mouse Model of Venous Thrombosis. Arterioscler Thromb Vasc Biol 39 : 311-318, 2019.
 
13) Takahashi M, Yamashita A, Moriguchi-Goto S, et al : Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis. Thromb Res 125 : 464-470, 2010.
 
14) Sugita C, Yamashita A, Matsuura Y, et al : Elevated plasma factor VIII enhances venous thrombus formation in rabbits : contribution of factor XI, von Willebrand factor and tissue factor. Thromb Haemost 110 : 62-75, 2013.
 
15) Martinod K, Demers M, Fuchs TA, et al : Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A 110 : 8674-8679, 2013.
 
P.90 掲載の参考文献
1) Amengual O, Atsumi T : Antiphospholipid syndrome, "the best prophet of the future". Mod Rheumatol 28 : 409-416, 2018.
PubMed
2) Bohgaki M, Atsumi T, Yamashita Y, et al : The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2 Glycoprotein I antibodies. Int Immunol 16 : 1633-1641, 2004.
 
3) Vega-Ostertag M, Harris EN, Pierangeli SS : Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum 50 : 2911-2919, 2004.
 
4) Wahl D, Membre A, Perret-Guillaume C, et al : Mechanisms of antiphospholipid-induced thrombosis : effects on the protein C system. Curr Rheumatol Rep 11 : 77-81, 2009.
 
5) Shibata S, Harpel PC, Gharavi A, et al : Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 83 : 2532-2540, 1994.
 
6) Oku K, Atsumi T, Bohgaki M, et al : Complement activation in patients with primary antiphospholipid syndrome. Ann Rheum Dis 68 : 1030-1035, 2009.
 
7) Tanimura K, Jin H, Suenaga T, et al : β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood 125 : 2835-2844, 2015.
 
8) Knight JS, Kanthi Y : Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol 44 : 347-362, 2022.
 
9) Atsumi T, Ieko M, Bertolaccini ML, et al : Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 43 : 1982-1993, 2000.
 
10) Pengo V, Tripodi A, Reber G, et al : Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 7 : 1737-1740, 2009.
 
11) Sakai Y, Atsumi T, Ieko M, et al : The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum 60 : 2457-2467, 2009.
 
12) Zhu R, Cheng CY, Yang Y, et al : Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome : A systematic review and meta-analysis. Thromb Res 214 : 106-114, 2022.
 
13) Miyakis S, Lockshin MD, Atsumi T, et al : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 : 295-306, 2006.
 
14) Tektonidou MG, Andreoli L, Limper M, et al : EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78 : 1296-1304, 2019.
 
15) 抗リン脂質抗体症候群 (APS). 抗リン脂質抗体症候群・好酸球性多発血管炎性肉芽腫症・結節性多発動脈炎・リウマトイド血管炎の治療の手引き 2020 (針谷正祥編), p15-38, 診断と治療社, 2021.
 
16) Khairani CD, Bejjani A, Piazza G, et al : Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes : Meta-Analysis of Randomized Trials. J Am Coll Cardiol 81 : 16-30, 2023.
 
17) Okuma H, Kitagawa Y, Yasuda T, et al : Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome. Int J Med Sci 7 : 15-18, 2009.
 
18) 抗リン脂質抗体症候群合併妊娠の診療ガイドライン (平成27年度日本医療研究開発機構成育疾患克服等総合研究事業「抗リン脂質抗体症候群合併妊娠の治療及び予後に関する研究」研究班編), 南山堂, 2016.
 
P.96 掲載の参考文献
1) Szecsi PB, Jorgensen M, Klajnbard A, et al : Haemostatic reference intervals in pregnancy. Thromb Haemost 103 : 718-727, 2010.
 
2) Mitsuguro M, Okamoto A, Shironouchi Y, et al : Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin. Int J Hematol 101 : 119-125, 2015.
 
3) Neki R, Mitsuguro M, Okamoto A, et al : A less-intensive anticoagulation protocol of therapeutic unfractionated heparin administration for pregnant patients. Int J Hematol 110 : 550-558, 2019.
 
4) Lamont MC, McDermott C, Thomson AJ, et al : United Kingdom recommendations for obstetric venous thromboembolism prophylaxis : Evidence and rationale. Semin Perinatol 43 : 222-228, 2019.
 
5) Bauersachs RM, Dudenhausen J, Faridi A, et al : Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 98 : 1237-1245, 2007.
 
6) Raia-Barjat T, Edebiri O, Chauleur C : Venous Thromboembolism Risk Score and Pregnancy. Front Cardiovasc Med 9 : 863612, 2022.
 
7) James AH : Pregnancy-associated thrombosis. Hematology Am Soc Hematol Educ Program 2009 : 277-285, 2009.
 
8) Knight M, Bunch K, Tuffnell D, et al (Eds.) : on behalf of MBRRACE-UK. Saving Lives, Improving Mothers' Care-Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2017-19. Oxford : National Perinatal Epidemiology Unit, University of Oxford, 2021.
 
9) Sugiura-Ogasawara M, Ebara T, Matsuki T, et al : Endometriosis and Recurrent Pregnancy Loss as New Risk Factors for Venous Thromboembolism during Pregnancy and Post-Partum : The JECS Birth Cohort. Thromb Haemost 119 : 606-617, 2019.
 
10) 妊産婦死亡症例検討評価委員会, 日本産婦人科医会 : 母体安全への提言 2022 Vol.13, 2023.
 
11) 小林隆夫, 森下英里子, 津田博子, ほか : 遺伝性血栓性素因患者の妊娠分娩管理に関する診療の手引き Q&A. 日本産婦人科・新生児血液学会誌 30 : 5-54, 2021.
 
12) 根木玲子, 宮田敏行 : 特発性血栓症. 遺伝子医学 13 : 110-119, 2023.
 
13) Neki R, Fujita T, Kokame K, et al : Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum. Int J Hematol 94 : 150-155, 2011.
 
14) 根木玲子, 宮田敏行 : 不育症と先天性血栓性素因. 日本血栓止血学会誌 27 : 339-348, 2016.
 
15) Kobayashi T, Sugiura K, Ojima T, et al : Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan. Thromb J 22 : 18, 2024.
PubMed
16) Garcia D, Erkan D : Diagnosis and Management of the Antiphospholipid Syndrome. N Engl J Med 378 : 2010-2021, 2018.
PubMed
P.102 掲載の参考文献
1) Nakamura M, Miyata T, Ozeki Y, et al : Current venous thromboembolism management and outcomes in Japan. Circ J 78 : 708-717, 2014.
 
2) Yamashita Y, Morimoto T, Amano H, et al : Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry. Circ J 82 : 1262-1270, 2018.
 
3) Khorana AA, Francis CW, Culakova E, et al : Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5 : 632-634, 2007.
 
4) Varki A : Trousseau' s syndrome : multiple definitions and multiple mechanisms. Blood 110 : 1723-1729, 2007.
 
5) 窓岩清治 : がんと線溶 (臨床). 日本血栓止血学会誌 33 : 321-328, 2022.
 
6) Trousseau A : Phlegmasia alba dolens. Clin Med Hotel Dieu De Paris 3 : 94, 1865.
 
7) 脳卒中治療ガイドライン 2021 [改訂2023] (日本脳卒中学会脳卒中ガイドライン委員会編), 協和企画, 2023.
 
8) Bagot CN, Arya R : Virchow and his triad : a question of attribution. Br J Haematol 143 : 180-190, 2008.
 
9) Mahajan A, Brunson A, Adesina O, et al : The incidence of cancer-associated thrombosis is increasing over time. Blood Adv 6 : 307-320, 2022.
 
10) 鳥越万紀夫, 伊村美紀, 山本恒久, ほか : がん関連血栓症 : その疫学, リスク因子, 腫瘍循環器連携の役割について. Therapeutic Research 44 : 491-503, 2023.
 
11) Takahashi S, Imura M, Katada J : Epidemiology and Treatment Patterns of Venous Thromboembolism : an Observational Study of Nationwide Time-Series Trends in Japan. Cardiol Ther 11 : 589-609, 2022.
 
12) Ohashi Y, Ikeda M, Kunitoh H, et al : One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment : Results from the Cancer-VTE Registry. Thromb Res 213 : 203-213, 2022.
 
13) Mulder FI, Horvath-Puho E, van Es N, et al : Venous thromboembolism in cancer patients : a population-based cohort study. Blood 137 : 1959-1969, 2021.
 
14) Lyon AR, Lopez-Fernandez T, Couch LS, et al : 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (ICOS). Eur Heart J 43 : 4229-4361, 2022.
 
15) Yamashita Y, Bikdeli B, Monreal M, et al : Difference between Japanese and White patients with acute pulmonary embolism. Thromb Res 204 : 52-56, 2021.
 
P.109 掲載の参考文献
1) den Dunnen JT, Dalgleish R, Maglott DR, et al : HGVS Recommendations for the Description of Sequence Variants : 2016 Update. Hum Mutat 37 : 564-569, 2016.
 
2) Tamura S, Hashimoto E, Suzuki N, et al : Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency. Thromb Res 178 : 159-170, 2019.
 
3) Miyata T, Sakata T, Yasumuro Y, et al : Genetic analysis of protein C deficiency in nineteen Japanese families : five recurrent defects can explain half of the deficiencies. Thromb Res 92 : 181-187, 1998.
 
4) 山本晃士 : プロテインC (PC) 欠乏症. 日本血栓止血学会誌 12 : 149-153, 2001.
 
5) Branchini A : The carboxyl-terminal region of coagulation serine proteases : A matter of cut and change. J Thromb Haemost 19 : 917-919, 2021.
 
6) 鈴木伸明 : 抗Tissue factor pathway inhibitor (TFPI) 薬の基礎と臨床. 日本血栓止血学会誌 33 : 23-30, 2022.
 
7) 津田博子 : ビタミンK依存性タンパク質プロテインS-機能と病態との関連-. 日本血栓止血学会誌 30 : 642-651, 2019.
 
8) Suzuki A, Sanda N, Miyawaki Y, et al : Down-regulation of PROS1 gene expression by 17β-estradiol via estrogen receptor alpha (ERalpha) -Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J Biol Chem 285 : 13444-13453, 2010.
 
9) Kinoshita S, Iida H, Inoue S, et al : Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 38 : 908-915, 2005.
 
10) Miyawaki Y, Suzuki A, Fujita J, et al : Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 366 : 2390-2396, 2012.
 
11) Djordjevic V, Kovac M, Miljic P, et al : A novel prothrombin mutation in two families with prominent thrombophilia-the first cases of antithrombin resistance in a Caucasian population. J Thromb Haemost 11 : 1936-1939, 2013.
 
12) Bulato C, Radu CM, Campello E, et al : New prothrombin mutation (Arg596Trp, prothrombin Padua 2) associated with venous thromboembolism. Arterioscler Thromb Vasc Biol 36 : 1022-1029, 2016.
 
13) Wu X, Dai J, Xu X, et al : Prothrombin Arg541Trp mutation leads to defective PC (protein C) pathway activation and constitutes a novel genetic risk factor for venous thrombosis. Arterioscler Thromb Vasc Biol 40 : 483-494, 2020.
 
14) Dahlback B : Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112 : 19-27, 2008.
 
15) Margaglione M, Grandone E : Population genetics of venous thromboembolism. A narrative review. Thromb Haemost 105 : 221-231, 2011.
 

II 動脈・静脈疾患の検査

P.118 掲載の参考文献
1) 動脈硬化性疾患予防ガイドライン [2022年版] (日本動脈硬化学会編), 日本動脈硬化学会, 2022.
 
2) Friedewald WT, Levy RI, Fredrickson DS : Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 : 499-502, 1972.
 
3) Sniderman AD, Thanassoulis G, Glavinovic T, et al : Apolipoprotein B Particles and Cardiovascular Disease : A Narrative Review. JAMA Cardiol 4 : 1287-1295, 2019.
 
4) Ross R, Glomset J, Harker L : Response to injury and atherogenesis. Am J Pathol 86 : 675-684, 1977.
 
5) Williams KJ, Tabas I : The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15 : 551-561, 1995.
PubMed
6) Holvoet P, Collen D, Van de Werf F : Malondialdehyde-modified LDL as a marker of acute coronary syndromes. JAMA 281 : 1718-1721, 1999.
 
7) Varbo A, Benn M, Tybjarg-Hansen A, et al : Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 61 : 427-436, 2013.
 
8) Boren J, Chapman MJ, Krauss RM, et al : Low-density lipoproteins cause atherosclerotic cardiovascular disease : pathophysiological, genetic, and therapeutic insights : a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41 : 2313-2330, 2020.
 
9) Grundy SM, Stone NJ, Bailey AL, et al : 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139 : e1082-e1143, 2019.
 
10) Mach F, Baigent C, Catapano AL, et al : 2019 ESC/EAS Guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk. Eur Heart J 41 : 111-188, 2020.
PubMed
11) O'Donoghue ML, Fazio S, Giugliano RP, et al : Lipoprotein (a), PCSK9 Inhibition, and Cardiovascular Risk. Circulation 139 : 1483-1492, 2019.
 
12) Thanassoulis G, Williams K, Ye K, et al : Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy : a meta-analysis of randomized trials. J Am Heart Assoc 3 : e000759, 2014.
 
13) Pencina MJ, D'Agostino RB, Zdrojewski T, et al : Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. Eur J Prev Cardiol 22 : 1321-1327, 2015.
 
14) Kastelein JJ, van der Steeg WA, Holme I, et al : Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 117 : 3002-3009, 2008.
 
15) Willerson JT, Ridker PM : Inflammation as a cardiovascular risk factor. Circulation 109 : II2-II10, 2004.
 
16) Yasunaga T, Ikeda S, Koga S, et al : Plasma pentraxin 3 is a more potent predictor of endothelial dysfunction than high-sensitive C-reactive protein. Int Heart J 55 : 160-164, 2014.
 
P.124 掲載の参考文献
1) 日本脳神経超音波学会・栓子検出と治療学会合同ガイドライン作成委員会 : 頭蓋内超音波検査ガイドライン. Neurosonology 19 : 113-131, 2006.
Medical*Online
2) 日本脳神経超音波学会・日本栓子検出と治療学会合同ガイドライン作成委員会 : 頭蓋内超音波検査ガイドライン (補遺). Neurosonology 20 : 11-12, 2007.
 
3) 日本脳神経超音波学会・栓子検出と治療学会合同ガイドライン作成委員会 : 頸部血管超音波検査ガイドライン. Neurosonology 19 : 49-69, 2006.
 
4) 日本超音波医学会用語・診断基準委員会, 頸動脈超音波診断ガイドライン小委員会 : 超音波による頸動脈病変の標準的評価法 2017. [https://www.jsum.or.jp/committee/diagnostic/pdf/jsum0515_guideline.pdf] (2024 年4 月閲覧)
 
5) 日本循環器学会. 血管炎症候群の診療ガイドライン (2017年改訂版), 2018. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2017_isobe_h.pdf] (2024年4月閲覧)
 
6) 日本超音波医学会用語・診断基準委員会, 大動脈・末梢動脈超音波診断ガイドライン小委員会 : 超音波による大動脈・末梢動脈病変の標準的評価法. Jpn J Med Ultrasonics 41 : 405-414, 2014.
 
7) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年4月閲覧)
 
8) 日本超音波医学会用語・診断基準委員会 : 超音波による大動脈病変の標準的評価法 2020, 2021. [https://www.jsum.or.jp/committee/diagnostic/pdf/aorticlesion2020.pdf] (2024年4月閲覧)
 
9) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年4月閲覧)
 
10) 日本循環器学会/日本心臓病学会/日本心臓血管外科学会/日本血管外科学会/日本胸部外科学会. 2021年改訂版先天性心疾患, 心臓大血管の構造的疾患 (structural heart disease) に対するカテーテル治療のガイドライン, 2021. [https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Sakamoto_Kawamura.pdf] (2024年4月閲覧)
 
11) 日本超音波医学会用語・診断基準委員会, 腎動脈超音波診断ガイドライン小委員会 : 超音波による腎動脈病変の標準的評価法. Jpn J Med Ultrasonics 42 : 185-200, 2015.
 
P.132 掲載の参考文献
1) Mehard WB, Heiken JP, Sicard GA : High-attenuating crescent in abdominal aortic aneurysm wall at CT : a sign of acute or impending rupture. Radiology 192 : 359-362, 1994.
PubMed
2) Ueda T, Hayashi H, Ando T, et al : Computed Tomography Attenuation Values of the High-Attenuating Crescent Sign Can Discriminate Between Rupture, Impending Rupture, and Non-Rupture of Aortic Aneurysms. Circ J 85 : 2184-2190, 2021.
 
3) Arita T, Matsunaga N, Takano K, et al : Abdominal aortic aneurysm : rupture associated with the high-attenuating crescent sign. Radiology 204 : 765-768, 1997.
 
4) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧)
 
5) Williams DM, Joshi A, Dake MD, et al : Aortic cobwebs : an anatomic marker identifying the false lumen in aortic dissection-imaging and pathologic correlation. Radiology 190 : 167-174, 1994.
 
6) Yamada T, Tada S, Harada J : Aortic dissection without intimal rupture : diagnosis with MR imaging and CT. Radiology 168 : 347-352, 1988.
 
7) Williams DM, Lee DY, Hamilton BH, et al : The dissected aorta : part III. Anatomy and radiologic diagnosis of branch-vessel compromise. Radiology 203 : 37-44, 1997.
 
8) Ota H, Takase K, Rikimaru H, et al : Quantitative vascular measurements in arterial occlusive disease. Radiographics 25 : 1141-1158, 2005.
 
9) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン, 2022. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年5月閲覧)
 
P.138 掲載の参考文献
1) Nash K, Hafeez A, Hou S : Hospital-acquired renal insufficiency. Am J Kidney Dis 39 : 930-936, 2002.
 
2) Michaely HJ, Aschauer M, Deutschmann H, et al : Gadobutrol in Renally Impaired Patients : Results of the GRIP Study. Invest Radiol 52 : 55-60, 2017.
 
3) Yamamoto T, Okada T, Fushimi Y, et al : Magnetic resonance angiography with compressed sensing : An evaluation of moyamoya disease. PLoS One 13 : e0189493, 2018.
 
4) Wu X, Deng L, Li W, et al : Deep Learning-Based Acceleration of Compressed Sensing for Noncontrast-Enhanced Coronary Magnetic Resonance Angiography in Patients With Suspected Coronary Artery Disease. J Magn Reson Imaging 58 : 1521-1530, 2023.
 
5) Hansmann J, Morelli JN, Michaely HJ, et al : Nonenhanced ECG-gated quiescent-interval single shot MRA : image quality and stenosis assessment at 3 tesla compared with contrast-enhanced MRA and digital subtraction angiography. J Magn Reson Imaging 39 : 1486-1493, 2014.
 
6) Zhang N, Zou L, Huang Y, et al : Non-Contrast Enhanced MR Angiography (NCE-MRA) of the Calf : A Direct Comparison between Flow-Sensitive Dephasing (FSD) Prepared Steady-State Free Precession (SSFP) and Quiescent-Interval Single-Shot (QISS) in Patients with Diabetes. PLoS One 10 : e0128786, 2015.
 
7) Miyazaki M, Sugiura S, Tateishi F, et al : Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 12 : 776-783, 2000.
 
8) Takehara Y : 4D Flow when and how? Radiol Med 125 : 838-850, 2020.
 
9) Ishikawa T, Takehara Y, Yamashita S, et al : Hemodynamic assessment in a child with renovascular hypertension using time-resolved three-dimensional cine phase-contrast MRI. J Magn Reson Imaging 41 : 165-168, 2015.
 
10) Katahashi K, Sano M, Takehara Y, et al : Flow dynamics of type II endoleaks can determine sac expansion after endovascular aneurysm repair using four-dimensional flow-sensitive magnetic resonance imaging analysis. J Vasc Surg 70 : 107-116.e1, 2019.
 
11) Yamanaka Y, Sano M, Katahashi K, et al : Pre-Operative Four Dimensional Flow Sensitive Magnetic Resonance Imaging Assessment of Aortic Side Branches as a Method to Predict Risk of Type II Endoleak Resulting in Sac Enlargement After EVAR. Eur J Vasc Endovasc Surg 66 : 17-26, 2023.
 
12) Ando J, Yamamoto K : Hemodynamic Forces, Endothelial Mechanotransduction, and Vascular Diseases. Magn Reson Med Sci 21 : 258-266, 2022.
 
13) Perera R, Isoda H, Ishiguro K, et al : Assessing the Risk of Intracranial Aneurysm Rupture Using Morphological and Hemodynamic Biomarkers Evaluated from Magnetic Resonance Fluid Dynamics and Computational Fluid Dynamics. Magn Reson Med Sci 19 : 333-344, 2020.
 
P.151 掲載の参考文献
1) Nishimura T, Nakajima K, Kusuoka H, et al : Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT : J-ACCESS study. Eur J Nucl Med Mol Imaging 35 : 319-328, 2008.
PubMed
2) Nakajima K, Kusuoka H, Nishimura S, et al : Prognostic value of myocardial perfusion and ventricular function in a Japanese multicenter cohort study (J-ACCESS) : the first-year total events and hard events. Ann Nucl Med 23 : 373-381, 2009.
 
3) Nakamura S, Kawano Y, Nakajima K, et al : Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial Perfusion imaging : Final 3-year report of the J-ACCESS 3 study. J Nucl Cardiol 26 : 431-440, 2019.
 
4) Nakajima K, Matsuo S, Okuyama C, et al : Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease. Circ J 76 : 168-175, 2012.
 
5) Ogasawara K, Yukawa H, Kobayashi M, et al : Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg 99 : 504-510, 2003.
PubMed
6) Walter MA, Melzer RA, Schindler C, et al : The value of [18F] FDG-PET in the diagnosis of largevessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32 : 674-681, 2005.
 
7) Ropp AM, Burke AP, Kligerman SJ, et al : Intimal Sarcoma of the Great Vessels. Radiographics 41 : 361-379, 2021.
 
8) Goldblum JR, Rice TW : Epithelioid angiosarcoma of the pulmonary artery. Hum Pathol 26 : 1275-1277, 1995.
 
P.158 掲載の参考文献
1) Ross R : Atherosclerosis-an inflammatory disease. N Engl J Med 340 : 115-126, 1999.
PubMed
2) Flammer AJ, Anderson T, Celermajer DS, et al : The assessment of endothelial function : from research into clinical practice. Circulation 126 : 753-767, 2012.
 
3) Brunner H, Cockcroft JR, Deanfield J, et al : Endothelial function and dysfunction. Part II : Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23 : 233-246, 2005.
 
4) Takase H, Dohi Y, Kimura G : Distribution of central blood pressure values estimated by Omron HEM-9000AI in the Japanese general population. Hypertens Res 36 : 50-57, 2013.
 
5) Matsuzawa Y, Kwon TG, Lennon RJ, et al : Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events : A Systematic Review and Meta-Analysis. J Am Heart Assoc 4 : e002270, 2015.
 
6) Tomiyama H, Ishizu T, Kohro T, et al : Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension. Int J Cardiol 253 : 161-166, 2018.
 
7) Tanaka A, Tomiyama H, Maruhashi T, et al : Physiological Diagnostic Criteria for Vascular Failure. Hypertension 72 : 1060-1071, 2018.
PubMed
8) Maruhashi T, Kajikawa M, Kishimoto S, et al : Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery. J Am Heart Assoc 9 : e013915, 2020.
 
9) Bonetti PO, Pumper GM, Higano ST, et al : Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44 : 2137-2141, 2004.
PubMed
10) Hamburg NM, Keyes MJ, Larson MG, et al : Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117 : 2467-2474, 2008.
 
11) Hamburg NM, Palmisano J, Larson MG, et al : Relation of brachial and digital measures of vascular function in the community : the Framingham heart study. Hypertension 57 : 390-396, 2011.
 
12) Rubinshtein R, Kuvin JT, Soffler M, et al : Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 31 : 1142-1148, 2010.
 
13) Shechter M, Matetzky S, Prasad M, et al : Endothelial function predicts 1-year adverse clinical outcome in patients hospitalized in the emergency department chest pain unit. Int J Cardiol 240 : 14-19, 2017.
 
14) Hayashi K : Experimental approaches on measuring the mechanical properties and constitutive laws of arterial walls. J Biomech Eng 115 : 481-488, 1993.
 
15) Laurent S, Cockcroft J, Van Bortel L, et al : Expert consensus document on arterial stiffness : methodological issues and clinical applications. Eur Heart J 27 : 2588-2605, 2006.
 
16) Shirai K, Asmar R, Orimo H : Cardio-Ankle Vascular Index : Overview & Clinical Application, Compass, 2021.
 
17) Ben-Shlomo Y, Spears M, Boustred C, et al : Aortic pulse wave velocity improves cardiovascular event prediction : an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 63 : 636-646, 2014.
 
18) Ohkuma T, Ninomiya T, Tomiyama H, et al : Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease : An Individual Participant Data Meta-Analysis. Hypertension 69 : 1045-1052, 2017.
 
19) Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, et al : Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index : a systematic review and meta-analysis. Hypertension 60 : 556-562, 2012.
 
20) Shirai K, Utino J, Otsuka K, et al : A novel blood pressure-independent arterial wall stiffness parameter ; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 13 : 101-107, 2006.
 
21) Saiki A, Sato Y, Watanabe R, et al : The Role of a Novel Arterial Stiffness Parameter, Cardio-Ankle Vascular Index (CAVI), as a Surrogate Marker for Cardiovascular Diseases. J Atheroscler Thromb 23 : 155-168, 2016.
 
22) Gerhard-Herman MD, Gornik HL, Barrett C, et al : 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135 : e726-e779, 2017.
 
P.164 掲載の参考文献
1) Nakamura M, Yamada N, Ito M : Current management of venous thromboembolism in Japan : Current epidemiology and advances in anticoagulant therapy. J Cardiol 66 : 451-459, 2015.
 
2) Stein PD, Hull RD, Patel KC, et al : D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism : a systematic review. Ann Intern Med 140 : 589-602, 2004.
 
3) Gervaso L, Dave H, Khorana AA : Venous and Arterial Thromboembolism in Patients With Cancer : JACC : CardioOncology State-of-the-Art Review. JACC CardioOncol 3 : 173-190, 2021.
 
4) 杉浦和子 : わが国における女性ホルモン剤と血栓症の実態-全国疫学調査結果より-. 日本血栓止血学会誌 32 : 632-634, 2021.
 
5) 日本静脈学会肺塞栓症研究会, 日本血管外科学会, ほか : 新型コロナウイルス感染症 (COVID-19) における静脈血栓塞栓症予防および抗凝固療法の診療指針 2021年10月5日版 (Version 3.0).
 
6) 松本知沙, 冨山博史 : 国内外の末梢血管疾患の疫学. 日本循環器病予防学会誌 57 : 161-172, 2022.
 
7) 森下英理子 : 血液 ; 動脈・静脈疾患の検査. 静脈疾患の検査. 日本臨牀 75 (増刊 : 動脈・静脈の疾患 (上)) : 196-200, 2017.
 
8) 柏木浩和 : 本態性血小板血症の診断と治療. 日本血栓止血学会誌 19 : 206-209, 2008.
 
9) Barbhaiya M, Zuily S, Naden R, et al : 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 82 : 1258-1270, 2023.
PubMed
10) Miyakis S, Lockshin MD, Atsumi T, et al : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 : 295-306, 2006.
 
11) 堀田哲也, 小池隆夫 : 抗リン脂質抗体症候群の病態と治療の最新の理解. 日本内科学会雑誌 97 : 1334-1340, 2008.
 
12) 森下英理子 : 先天性血栓性素因の診断の進め方. 日本血栓止血学会誌 19 : 416-421, 2008.
 
13) 日本循環器学会/日本心臓病学会/日本小児循環器学会. 2024年改訂版心臓血管疾患における遺伝学的検査と遺伝カウンセリングに関するガイドライン, 2024. [https://www.j-circ.or.jp/cms/wp-content/uploads/2024/03/JCS2024_Imai.pdf] (2024年4月閲覧)
 
14) 森下英理子 : 血液凝固異常症の臨床と検査-血栓性素因の診断-. 日本血栓止血学会誌 19 : 467-470, 2008.
 
P.171 掲載の参考文献
1) De Maeseneer MG, Kakkos SK, Aherne T, et al : Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg 63 : 184-267, 2022.
 
2) 松尾汎, 佐戸川弘之, 小川智弘, ほか : 超音波による深部静脈血栓症・下肢静脈瘤の標準的評価法. 静脈学 29 : 363-394, 2018.
 
3) 広川雅之, 佐戸川弘之, 八杉巧, ほか : 下肢静脈瘤に対する血管内焼灼術のガイドライン 2019. 静脈学 30 (Suppl) : i-81, 2019.
 
4) 白杉望, 小畑貴司, 杉山悟, ほか : 下肢静脈瘤の超音波検査所見の標準的記載法, 静脈学 32 : 349-353, 2021.
 
P.176 掲載の参考文献
1) Yeh BM, Kurzman P, Foster E, et al : Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT. AJR Am J Roentgenol 183 : 1227-1232, 2004.
 
2) Chung I, Lip GYH : Virchow's triad revisited : blood constituents. Pathophysiol Haemost Thromb 33 : 449-454, 2003.
 
3) Duwe KM, Shiau M, Budorick NE, et al : Evaluation of the lower extremity veins in patients with suspected pulmonary embolism : a retrospective comparison of helical CT venography and sonography. 2000 ARRS Executive Council Award I. American Roentgen Ray Society. AJR Am J Roentgenol 175 : 1525-1531, 2000.
 
4) Bass JE, Redwine MD, Kramer LA, et al : Spectrum of congenital anomalies of the inferior vena cava : cross-sectional imaging findings. Radiographics 20 : 639-652, 2000.
 
5) 桑子智之, 林宏光, 汲田伸一郎 : 重複下大静脈. ここから始める循環器疾患のCT・MRI心臓・頸部血管・胸部・腹部・末梢血管疾患Case Review (似鳥俊明, 横山健一編著), p214-215, 学研メディカル秀潤社, 2020.
 
P.182 掲載の参考文献
1) Cochran RL, Ghoshhajra BB, Hedgire SS : Body and Extremity MR Venography : Technique, Clinical Applications, and Advances. Magn Reson Imaging Clin N Am 31 : 413-431, 2023.
 
2) Tan EJ, Zhang S, Tirukonda P, et al : REACT - A novel flow-independent non-gated non-contrast MR angiography technique using magnetization-prepared 3D non-balanced dual-echo dixon method : Preliminary clinical experience. Eur J Radiol Open 7 : 100238, 2020.
 
3) Dieleman N, van der Kolk AG, Zwanenburg JJ, et al : Imaging intracranial vessel wall pathology with magnetic resonance imaging : current prospects and future directions. Circulation 130 : 192-201, 2014.
 
4) Kiryu S, Akai H, Yasaka K, et al : Clinical Impact of Deep Learning Reconstruction in MRI. Radiographics 43 : e220133, 2023.
 
P.188 掲載の参考文献
1) 日本循環器学会. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版), 2018. [https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf] (2024年5月閲覧)
 
2) Neste MG, Narasimham DL, Belcher KK : Endovascular Stent Placement as a Treatment for Renal Venous hypertension. J Vasc Interv Radiol 7 : 859-861, 1996.
 
3) Capasso P, Simons C, Trotteur G, et al : Treatment of symptomatic pelvic varices by ovarian vein embolization. Cardiovasc Intervent Radiol 20 : 107-111, 1997.
 
4) Neves da Silva HV, Meller RL, Ogundipe EA, et al : Varicoceles : overview of treatment from a radiologic and surgical perspective. Semin Intervent Radiol 39 : 490-497, 2022.
 
5) 膵・消化管神経内分泌腫瘍 (NET) 診療ガイドライン 2015年 [第1版] (日本神経内分泌腫瘍研究会 (JNETS) 膵・消化管神経内分泌腫瘍診療ガイドライン作成委員会編), 金原出版, 2015.
 
6) 中村健治 : 経静脈的肝内門脈静脈短絡術 (TIPS). IVRマニュアル (打田日出夫, 山田龍作監, 栗林幸夫, 中村健治, 廣田省三, ほか編), p159-165, 医学書院, 2002.
 
7) Kiyosue H, Mori H, Matsumoto S, et al : Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics 23 : 911-920, 2003.
 
8) Zurcher KS, Smith MV, Naidu SG, et al : Transsplenic Portal System Catheterization : Review of Current Indications and Techniques. Radiographics 42 : 1562-1576, 2022.
 
9) Yamao T, Tamura Y, Hayashi H, et al : Novel Approach via the Round Ligament in Portal Vein Embolization. World J Surg 45 : 2878-2885, 2021.
 

III 動脈・静脈疾患 ( 四肢, 体幹 )

P.195 掲載の参考文献
1) Coady MA, Rizzo JA, Hammond GL, et al : What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 113 : 476-491 ; discussion 489-491, 1997.
 
2) Bashir M, Fok M, Hammoud I, et al : A Perspective on Natural History and Survival in Nonoperated Thoracic Aortic Aneurysm Patients. Aorta (Stamford) 1 : 182-189, 2013.
 
3) Sawada H, Rateri DL, Moorleghen JJ, et al : Smooth Muscle Cells Derived From Second Heart Field and Cardiac Neural Crest Reside in Spatially Distinct Domains in the Media of the Ascending Aorta-Brief Report. Arterioscler Thromb Vasc Biol 37 : 1722-1726, 2017.
 
4) Cheung K, Boodhwani M, Chan KL, et al : Thoracic Aortic Aneurysm Growth : Role of Sex and Aneurysm Etiology. J Am Heart Assoc 6 : e003792, 2017.
 
5) Writing Committee Members ; Isselbacher EM, Preventza O, Black JH 3rd : 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease : A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 80 : e223-e393, 2022.
 
6) Launay D, Hachulla E : [Inflammatory aortitis]. Presse Med 33 (19 Pt 1) : 1334-1340, 2004.
 
7) Thakker PD, Braverman AC : Cardiogenetics : genetic testing in the diagnosis and management of patients with aortic disease. Heart 107 : 619-626, 2021.
 
8) Biddinger A, Rocklin M, Coselli J, et al : Familial thoracic aortic dilatations and dissections : a case control study. J Vasc Surg 25 : 506-511, 1997.
 
9) LeMaire SA, Carter SA, Volguina IV, et al : Spectrum of aortic operations in 300 patients with confirmed or suspected Marfan syndrome. Ann Thorac Surg 81 : 2063-2078, 2006.
 
10) Lee WK, Mossop PJ, Little AF, et al : Infected (mycotic) aneurysms : spectrum of imaging appearances and management. Radiographics 28 : 1853-1868, 2008.
 
11) Gornik HL, Creager MA : Aortitis. Circulation 117 : 3039-3051, 2008.
 
12) Deng J, Li D, Zhang X, et al : Murine model of elastase-induced proximal thoracic aortic aneurysm through a midline incision in the anterior neck. Front Cardiovasc Med 10 : 953514, 2023.
 
13) Gao J, Cao H, Hu G, et al : The mechanism and therapy of aortic aneurysms. Signal Transduct Target Ther 8 : 55, 2023.
 
14) Hsieh CC, Yen MH, Yen CH, et al : Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res 49 : 135-145, 2001.
 
15) Airhart N, Brownstein BH, Cobb JP, et al : Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin. J Vasc Surg 60 : 1033-1042, 2014.
 
P.201 掲載の参考文献
1) Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery ; Shimizu H, Okada M, Toh Y, et al : Thoracic and cardiovascular surgeries in Japan during 2018 : Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 69 : 179-212, 2021.
PubMed
2) Cooke JC, Cambria RP : Simultaneous tracheobronchial and esophageal obstruction caused by a descending thoracic aneurysm. J Vasc Surg 18 : 90-94, 1993.
 
3) Stather PW, Sidloff DA, Dattani N, et al : Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg 101 : 1358-1372, 2014.
 
4) Balmforth D, Harky A, Adams B, et al : Is there a role for biomarkers in thoracic aortic aneurysm disease? Gen Thorac Cardiovasc Surg 67 : 12-19, 2019.
 
5) Folsom AR, Yao L, Alonso A, et al : Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence : The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 132 : 578-585, 2015.
 
6) Aboulafia DM, Aboulafia ED : Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg 10 : 396-405, 1996.
 
7) Fine NL, Applebaum J, Elguezabal A, et al : Multiple coagulation defects in association with dissecting aneurysm. Arch Intern Med 119 : 522-526, 1967.
 
8) Asakura H : Classifying types of disseminated intravascular coagulation : clinical and animal models. J Intensive Care 2 : 20, 2014.
PubMed
9) Kasashima S, Zen Y, Kawashima A, et al : A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 49 : 1264-1271, 2009.
 
10) Erbel R, Aboyans V, Boileau C, et al : 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35 : 2873-2926, 2014.
 
11) Hirose Y, Hamada S, Takamiya M, et al : Aortic aneurysms : growth rates measured with CT. Radiology 185 : 249-252, 1992.
 
12) Takase K, Sawamura Y, Igarashi K, et al : Demonstration of the artery of Adamkiewicz at multi-detector row helical CT. Radiology 223 : 39-45, 2002.
 
13) Rakita D, Newatia A, Hines JJ, et al : Spectrum of CT findings in rupture and impending rupture of abdominal aortic aneurysms. Radiographics 27 : 497-507, 2007.
 
14) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧)
 
15) Takagi H, Ota H, Natsuaki Y, et al : Identifying the Adamkiewicz artery using 3-T time-resolved magnetic resonance angiography : its role in addition to multidetector computed tomography angiography. Jpn J Radiol 33 : 749-756, 2015.
 
P.206 掲載の参考文献
1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧)
 
2) Levine D, Patel P, Wang C, et al : Valve-Sparing Root Replacement versus Composite Valve Graft Root Replacement : Analysis of more than 1500 Patients from 2 Aortic Centers. J Thorac Cardiovasc Surg, 2023. [DOI : 10.1016/j.jtcvs.2023.05.022]
 
3) Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al : 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease : A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 146 : e334-e482, 2022.
 
4) Czerny M, Grabenwoger M, Berger T, et al : EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. Eur J Cardiothorac Surg 65 : ezad42d, 2024.
 
5) Tanaka A, Al-Rstum Z, Zhou N, et al : Feasibility and Durability of the Modified Cabrol Coronary Artery Reattachment Technique. Ann Thorac Surg 110 : 1847-1853, 2020.
 
6) Kazui T, Yamashita K, Washiyama N, et al : Aortic arch replacement using selective cerebral perfusion. Ann Thorac Surg 83 : S796-798 ; discussion S824-831, 2007.
 
7) Okada K : Total arch replacement : When and how? Asian Cardiovasc Thorac Ann 31 : 42-47, 2023.
 
8) Leone A, Di Marco L, Coppola G, et al : Open distal anastomosis in the frozen elephant trunk technique : initial experiences and preliminary results of arch zone 2 versus arch zone 3. Eur J Cardiothorac Surg 56 : 564-571, 2019.
 
9) Ogino H, Okita Y, Uchida N, et al : Comparative study of Japanese frozen elephant trunk device for open aortic arch repairs. J Thorac Cardiovasc Surg 164 : 1681-1692, 2022.
 
10) Seike Y, Matsuda H, Fukuda T, et al : Is debranching thoracic endovascular aortic repair acceptable as the first choice for arch aneurysm in the elderly? Interact Cardiovasc Thorac Surg 29 : 101-108, 2019.
 
11) Omura A, Minatoya K, Matsuo J, et al : Early and late outcomes of open repair for dissecting aneurysms of the descending or thoraco-abdominal aorta. Interact Cardiovasc Thorac Surg 25 : 950-957, 2017.
 
12) Coselli JS, LeMaire SA, Preventza O, et al : Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg 151 : 1323-1337, 2016.
 
13) Tanaka H, Ogino H, Minatoya K, et al : The impact of preoperative identification of the Adamkiewicz artery on descending and thoracoabdominal aortic repair. J Thorac Cardiovasc Surg 151 : 122-128, 2016.
 
14) Yamanaka K, Hasegawa S, Kawabata R, et al : Anterolateral thoracotomy with partial sternotomy : a feasible approach for treating the complex pathology of the aortic arch. Eur J Cardiothorac Surg 65 : ezae138, 2024.
 
P.209 掲載の参考文献
1) Golledge J, Thanigaimani S, Powell JT, et al : Pathogenesis and management of abdominal aortic aneurysm. Eur Heart J 44 : 2682-2697, 2023.
 
2) Golledge J : Abdominal aortic aneurysm : update on pathogenesis and medical treatments. Nat Rev Cardiol 16 : 225-242, 2019.
 
P.216 掲載の参考文献
1) Steinberg CR, Archer M, Steinberg I : Measurement of the Abdominal Aorta After Intravenous Aortography in Health and Arteriosclerotic Peripheral Vascular Disease. Am J Roentgenol Radium Ther Nucl Med 95 : 703-708, 1965.
 
2) Thompson RW, Geraghty PJ, Lee JK : Abdominal aortic aneurysms : basic mechanisms and clinical implications. Curr Probl Surg 39 : 110-230, 2002.
 
3) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧)
 
4) Akai T, Hoshina K, Yamamoto S, et al : Biomechanical Analysis of an Aortic Aneurysm Model and Its Clinical Application to Thoracic Aortic Aneurysms for Defining "Saccular" Aneurysms. J Am Heart Assoc 4 : e001547, 2015.
 
5) Natsume K, Shiiya N, Takehara Y, et al : Characterizing saccular aortic arch aneurysms from the geometry-flow dynamics relationship. J Thorac Cardiovasc Surg 153 : 1413-1420.e1, 2017.
 
6) Sterpetti AV, Feldhaus RJ, Schultz RD, et al : Identification of abdominal aortic aneurysm patients with different clinical features and clinical outcomes. Am J Surg 156 : 466-469, 1988.
 
7) Aboulafia DM, Aboulafia ED : Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg 10 : 396-405, 1996.
 
8) Sidloff DA, Stather PW, Choke E, et al : A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg 59 : 528-535.e4, 2014.
 
9) Chervu A, Clagett GP, Valentine RJ, et al : Role of physical examination in detection of abdominal aortic aneurysms. Surgery 117 : 454-457, 1995.
 
10) Goldstein SA, Evangelista A, Abbara S, et al : Multimodality imaging of diseases of the thoracic aorta in adults : from the American Society of Echocardiography and the European Association of Cardiovascular Imaging : endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 28 : 119-182, 2015.
 
11) Stather PW, Sidloff DA, Dattani N, et al : Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg 101 : 1358-1372, 2014.
 
12) 日本血栓止血学会学術標準化委員会DIC部会 : 科学的根拠に基づいた感染症に伴うDIC治療のエキスパートコンセンサス. 日本血栓止血学会誌 20 : 77-113, 2009.
 
P.222 掲載の参考文献
1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧)
 
2) Brewster DC, Cronenwett JL, Hallett JW Jr, et al : Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 37 : 1106-1117, 2003.
 
3) Wanhainen A, Van Herzeele I, Bastos Goncalves F, et al : Editor's Choice-European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. Eur J Vasc Endovasc Surg 67 : 192-331, 2024.
 
4) 日本血管外科学会データベース管理運営委員会, NCD血管外科データ解析チーム : 血管外科手術アニュアルレポート 2018年. 日本血管外科学会雑誌 31 : 217-237, 2022.
 
5) Senekowitsch C, Assadian A, Assadian O, et al : Replanting the inferior mesentery artery during infrarenal aortic aneurysm repair : influence on postoperative colon ischemia. J Vasc Surg 43 : 689-694, 2006.
 
6) Becquemin JP, Majewski M, Fermani N, et al : Colon ischemia following abdominal aortic aneurysm repair in the era of endovascular abdominal aortic repair. J Vasc Surg 47 : 258-263, 2008.
 
7) IMPROVE Trial Investigators ; Powell JT, Sweeting MJ, Thompson MM, et al : Endovascular or open repair strategy for ruptured abdominal aortic aneurysm : 30 day outcomes from IMPROVE randomised trial. BMJ 348 : f7661, 2014.
 
8) Reimerink JJ, Hoornweg LL, Vahl AC, et al : Endovascular repair versus open repair of ruptured abdominal aortic aneurysms : a multicenter randomized controlled trial. Ann Surg 258 : 248-256, 2013.
 
9) Desgranges P, Kobeiter H, Katsahian S, et al : Editor's Choice-ECAR (Endovasculaire ou Chirurgie dans les Anevrysmes aorto-iliaques Rompus) : A French Randomized Controlled Trial of Endovascular Versus Open Surgical Repair of Ruptured Aorto-iliac Aneurysms. Eur J Vasc Endovasc Surg 50 : 303-310, 2015.
 
10) Chaikof EL, Dalman RL, Eskandari MK, et al : The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 67 : 2-77.e2, 2018.
 
P.227 掲載の参考文献
1) Erbel R, Alfonso F, Boileau C, et al : Diagnosis and management of aortic dissection. Eur Heart J 22 : 1642-1681, 2001.
 
2) Khan IA, Nair CK : Clinical, diagnostic, and management perspectives of aortic dissection. Chest 122 : 311-328, 2002.
 
3) Yamaguchi T, Nakai M, Yano T, et al : Population-based incidence and outcomes of acute aortic dissection in Japan. Eur Heart J Acute Cardiovasc Care 10 : 701-709, 2021.
 
4) Moriyama S, Hara M, Hirota T, et al : Population-Based Study of the Incidence and Mortality Rate of Acute Aortic Dissection. Circ J 88 : 297-306, 2024.
 
5) Hagan PG, Nienaber CA, Isselbacher EM, et al : The International Registry of Acute Aortic Dissection (IRAD) : new insights into an old disease. JAMA 283 : 897-903, 2000.
 
6) Marcus ML, Heistad DD, Armstrong ML, et al : Effects of chronic hypertension on vasa vasorum in the thoracic aorta. Cardiovasc Res 19 : 777-781, 1985.
 
7) Angouras D, Sokolis DP, Dosios T, et al : Effect of impaired vasa vasorum flow on the structure and mechanics of the thoracic aorta : implications for the pathogenesis of aortic dissection. Eur J Cardiothorac Surg 17 : 468-473, 2000.
 
8) Osada H, Kyogoku M, Ishidou M, et al : Aortic dissection in the outer third of the media : What is the role of the vasa vasorum in the triggering process? Eur J Cardiothorac Surg 43 : e82-e88, 2013.
 
9) Del Porto F, di Gioia C, Tritapepe L, et al : The multitasking role of macrophages in Stanford type A acute aortic dissection. Cardiology 127 : 123-129, 2014.
 
10) Koullias GJ, Ravichandran P, Korkolis DP, et al : Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78 : 2106-2111, 2004.
 
11) Chae CU, Lee RT, Rifai N, et al : Blood pressure and inflammation in apparently healthy men. Hypertension 38 : 399-403, 2001.
 
12) Mussa FF, Horton JD, Moridzadeh R, et al : Acute aortic dissection and intramural hematoma a systematic review. JAMA 316 : 754-763, 2016.
 
13) Haverich A, Boyle EC : Aortic dissection is a disease of the vasa vasorum. JTCVS Open 5 : 30-32, 2021.
 
14) Clouse WD, Hallett JW Jr, Schaff HV, et al : Acute aortic dissection : population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc 79 : 176-180, 2004.
 
15) Januzzi JL, Isselbacher EM, Fattori R, et al : Characterizing the young patient with aortic dissection : results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 43 : 665-669, 2004.
 
16) Landenhed M, Engstrom G, Gottsater A, et al : Risk profiles for aortic dissection and ruptured or surgically treated aneurysms : a prospective cohort study. J Am Heart Assoc 4 : e001513, 2015.
 
17) Howard DP, Banerjee A, Fairhead JF, et al : Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control : 10-year results from the Oxford Vascular Study. Circulation 127 : 2031-2037, 2013.
 
18) Elefteriades JA : Natural History of Thoracic Aortic Aneurysms : Indications for Surgery, and Surgical Versus Nonsurgical Risks. Ann Thorac Surg 74 : S1877-S1880, 2002.
 
19) Perez ZG, Zafar MA, Velasco JJ, et al : Aortic Size at the Time of Type A and Type B Dissections. Ann Thorac Surg 116 : 262-268, 2023.
 
20) Erbel R, Aboyans V, Boileau C, et al ; ESC Committee for Practice Guidelines : 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35 : 2873-2926, 2014.
 
21) Evangelista A, Isselbacher EM, Bossone E, et al ; IRAD Investigators : Insights From the International Registry of Acute Aortic Dissection : A 20-Year Experience of Collaborative Clinical Research. Circulation 137 : 1846-1860, 2018.
 
22) Byers PH, Belmont J, Black J, et al : Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 175 : 40-47, 2017.
 
23) Meester JAN, Verstraeten A, Schepers D, et al : Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg 6 : 582-594, 2017.
 
24) Loeys BL, Schwarze U, Holm T, et al : Aneurysm syndromes caused by mutations in the TGF-β receptor. N Engl J Med 355 : 788-798, 2006.
 
25) Michelena HI, Khanna AD, Mahoney D, et al : Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 306 : 1104-1112, 2011.
 
26) Fukui T : Management of acute aortic dissection and thoracic aortic rupture. J Intensive Care 6 : 15, 2018.
 
27) Janosi RA, Buck T, Erbel R : Mechanism of coronary malperfusion due to type-a aortic dissection. Herz 34 : 478, 2009.
 
28) Gilon D, Mehta RH, Oh JK, et al : Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection. Am J Cardiol 103 : 1029-1031, 2009.
 
29) Januzzi JL, Eagle KA, Cooper JV, et al : Acute aortic dissection presenting with congestive heart failure : results from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol 46 : 733-735, 2005.
 
30) Berretta P, Trimarchi S, Patel HJ, et al : Malperfusion syndromes in type A aortic dissection : what we have learned from IRAD. J Vis Surg 4 : 65, 2018.
 
P.233 掲載の参考文献
1) 荻野均 : 大動脈解離 : 総論. 新心臓血管外科テキスト (安達秀雄, 小野稔, 坂本喜三郎, ほか編), p513-516, 中外医学社, 2016.
 
2) Yamaguchi T, Nakai M, Yano T, et al : Population-based incidence and outcomes of acute aortic dissection in Japan. Eur Heart J Acute Cardiovasc Care 10 : 701-709, 2021.
 
3) Tanaka Y, Sakata K, Sakurai Y, et al : Prevalence of Type A Acute Aortic Dissection in Patients With Out-Of-Hospital Cardiopulmonary Arrest. Am J Cardiol 117 : 1826-1830, 2016.
 
4) Higo Y, Sawayama Y, Takashima N, et al : Epidemiology of Acute Aortic Dissection in a General Population of 1.4 Million People in Japan-Shiga Stroke and Heart Attack Registry. Circ J 87 : 1155-1161, 2023.
 
5) Czerny M, Rylski B : Acute type A aortic dissection reconsidered : it's all about the location of the primary entry tear and the presence or absence of malperfusion. Eur Heart J 43 : 53-55, 2021.
 
6) Inoue Y, Matsuda H, Uchida K, et al : Analysis of Acute Type A Aortic Dissection in Japan Registry of Aortic Dissection (JRAD). Ann Thorac Surg 110 : 790-798, 2020.
 
7) Yamaguchi T, Nakai M, Sumita Y, et al : Impact of structural and process quality indicators on the outcomes of acute aortic dissection. Eur J Cardiothorac Surg 58 : 1281-1288, 2020.
 
8) Deeb GM, Williams DM, Bolling SF, et al : Surgical delay for acute type A dissection with malperfusion. Ann Thorac Surg 64 : 1669-1677, 1997.
 
9) Imoto K, Uchida K, Karube N, et al : Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection. Eur J Cardiothorac Surg 44 : 419-425, 2013.
 
10) Malaisrie SC, Szeto WY, Halas M, et al : 2021 The American Association for Thoracic Surgery expert consensus document : Surgical treatment of acute type A aortic dissection. J Thorac Cardiovasc Surg 162 : 735-758.e2, 2021.
 
11) Kreibich M, Desai ND, Bavaria JE, et al : Common carotid artery true lumen flow impairment in patients with type A aortic dissection. Eur J Cardiothorac Surg 59 : 490-496, 2021.
 
12) Fukuhara S, Norton EL, Chaudhary N, et al : Type A Aortic Dissection With Cerebral Malperfusion : New Insights. Ann Thorac Surg 112 : 501-509, 2021.
 
13) Inoue Y, Inoue M, Koga M, et al : Preoperative brain computed tomographic perfusion for quantitative evaluation of cerebral malperfusion caused by acute type A aortic dissection. JTCVS Tech 10 : 190-195, 2021.
 
14) Inoue Y, Inoue M, Koga M, et al : Novel brain computed tomography perfusion for cerebral malperfusion secondary to acute type A aortic dissection. Interact Cardiovasc Thorac Surg 35 : ivac046, 2022.
 
P.241 掲載の参考文献
1) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧).
 
2) Mehta RH, Suzuki T, Hagan PG, et al : Predicting death in patients with acute type a aortic dissection. Circulation 105 : 200-206, 2002.
 
3) Bachet J, Larrazet F, Goudot B, et al : When should the aortic arch be replaced in Marfan patients? Ann Thorac Surg 83 : S774-S790, 2007.
 
4) Kimura N, Itoh S, Yuri K, et al : Reoperation for enlargement of the distal aorta after initial surgery for acute type A aortic dissection. J Thorac Cardiovasc Surg 149 (Suppl) : S91-S98.e1, 2015.
 
5) Yamane Y, Uchida N, Mochizuki S, et al : Early- and mid-term aortic remodelling after the frozen elephant trunk technique for retrograde type A acute aortic dissection using the new Japanese J Graft open stent graft. Interact Cardiovasc Thorac Surg 25 : 720-726, 2017.
 
6) Inoue Y, Matsuda H, Omura A, et al : Comparative study of the frozen elephant trunk and classical elephant trunk techniques to supplement total arch replacement for acute type A aortic dissection. Eur J Cardiothorac Surg 56 : 579-586, 2019.
 
7) Yoshitake A, Tochii M, Tokunaga C, et al : Early and long-term results of total arch replacement with the frozen elephant trunk technique for acute type A aortic dissection. Eur J Cardiothorac Surg 58 : 707-713, 2020.
 
8) Neri E, Toscano T, Papalia U, et al : Proximal aortic dissection with coronary malperfusion : presentation, management, and outcome. J Thorac Cardiovasc Surg 121 : 552-560, 2001.
 
9) Kawahito K, Adachi H, Murata S, et al : Coronary malperfusion due to type A aortic dissection : mechanism and surgical management. Ann Thorac Surg 76 : 1471-1476, 2003.
 
10) Hiratzka LF, Bakris GL, Beckman JA, et al : 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121 : e266-e369, 2010.
 
11) Estrera AL, Garami Z, Miller CC, et al : Acute type A aortic dissection complicated by stroke : can immediate repair be performed safely? J Thorac Cardiovasc Surg 132 : 1404-1408, 2006.
 
12) Joshi D, Bicer EI, Donmez C, et al : Incremental value of live/real time three-dimensional transesophageal echocardiography over the two-dimensional technique in the assessment of aortic aneurysm and dissection. Echocardiography 29 : 620-630, 2012.
 
13) Cambria RP, Brewster DC, Gertler J, et al : Vascular complications associated with spontaneous aortic dissection. J Vasc Surg 7 : 199-209, 1988.
 
14) Girardi LN, Krieger KH, Lee LY, et al : Management strategies for type A dissection complicated by peripheral vascular malperfusion. Ann Thorac Surg 77 : 1309-1314, 2004.
 
15) Arthurs ZM, Titus J, Bannazadeh M, et al : A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg 53 : 698-705, 2011.
 
16) Lombardi JV, Hughes GC, Appoo JJ, et al : Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) Reporting Standards for Type B Aortic Dissections. Ann Thorac Surg 109 : 959-981, 2020.
 
17) Trimarchi S, Eagle KA, Nienaber CA, et al : Importance of refractory pain and hypertension in acute type B aortic dissection : insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 122 : 1283-1289, 2010.
 
18) Nienaber CA, Kische S, Rousseau H, et al : Endovascular repair of type B aortic dissection : long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 6 : 407-416, 2013.
 
19) Rylski B, Perez M, Beyersdorf F, et al : Acute non-A non-B aortic dissection : incidence, treatment and outcome. Eur J Cardiothorac Surg 52 : 1111-1117, 2017.
 
20) Fattori R, Cao P, De Rango P, et al : Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol 61 : 1661-1678, 2013.
 
21) Coselli JS, LeMaire SA, Preventza O, et al : Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg 151 : 1323-1337, 2016.
 
22) Erbel R, Aboyans V, Boileau C, et al : 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 35 : 2873-2926, 2014.
 
P.247 掲載の参考文献
1) Lee VH, Brown RD Jr, Mandrekar JN, et al : Incidence and outcome of cervical artery dissection : a population-based study. Neurology 67 : 1809-1812, 2006.
 
2) Debette S, Leys D : Cervical-artery dissections : predisposing factors, diagnosis, and outcome. Lancet Neurol 8 : 668-678, 2009.
 
3) Schievink WI, Mokri B, O'Fallon WM : Recurrent spontaneous cervical-artery dissection. N Engl J Med 330 : 393-397, 1994.
 
4) Beletsky V, Nadareishvili Z, Lynch J, et al : Cervical arterial dissection : time for a therapeutic trial? Stroke 34 : 2856-2860, 2003.
 
5) 山浦晶, 吉本高志, 橋本信夫, ほか : 非外傷性頭蓋内解離性動脈病変の全国調査 (第1報). 脳卒中の外科 26 : 79-86, 1998.
 
6) 小野純一, 樋口佳則, 田島洋佑, ほか : 椎骨脳底動脈系頭蓋内動脈解離の全国調査 (最終報告) 第1報-概要について-. 脳卒中の外科 43 : 245-251, 2015.
 
7) Dittrich R, Nassenstein I, Bachmann R, et al : Polyarterial clustered recurrence of cervical artery dissection seems to be the rule. Neurology 69 : 180-186, 2007.
 
8) Touze E, Gauvrit JY, Moulin T, et al : Risk of stroke and recurrent dissection after a cervical artery dissection : a multicenter study. Neurology 61 : 1347-1351, 2003.
 
9) Micheli S, Paciaroni M, Corea F, et al : Cervical artery dissection : emerging risk factors. Open Neurol J 4 : 50-55, 2010.
 
10) Keser Z, Chiang CC, Benson JC, et al : Cervical Artery Dissections : Etiopathogenesis and Management. Vasc Health Risk Manag 18 : 685-700, 2022.
 
11) Talarowska P, Dobrowolski P, Klisiewicz A, et al : High incidence and clinical characteristics of fibromuscular dysplasia in patients with spontaneous cervical artery dissection : The ARCADIAPOL study. Vasc Med 24 : 112-119, 2019.
 
12) Olin JW, Froehlich J, Gu X, et al : The United States Registry for Fibromuscular Dysplasia : results in the first 447 patients. Circulation 125 : 3182-3190, 2012.
 
13) Brandt T, Orberk E, Weber R, et al : Pathogenesis of cervical artery dissections : association with connective tissue abnormalities. Neurology 57 : 24-30, 2001.
 
14) Gunduz ME, Kadirvel R, Kallmes DF, et al : Spontaneous cervical artery dissection : is it really a connective tissue disease? A comprehensive review. Front Neurol 14 : 1241084, 2023.
 
15) Sun Z, Kleine-Borgmann J, Suh J, et al : Migraine and the risk of cervical artery dissection : A systematic review and meta-analysis. Eur Stroke J 8 : 904-914, 2023.
 
16) Daghals I, Sargurupremraj M, Danning R, et al : Migraine, Stroke, and Cervical Arterial Dissection : Shared Genetics for a Triad of Brain Disorders with Vascular Involvement. Neurol Genet 8 : e653, 2022.
 
17) Luo H, Liu B, Hu J, et al : Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in cervical artery dissection : a meta-analysis. Cerebrovasc Dis 37 : 313-322, 2014.
 
18) Haertl J, Renz M, Wunderlich S, et al : Bony Stroke : Ischemic Stroke Caused by Mechanical Stress on Brain Supplying Arteries From Anatomical Bone or Cartilage Anomalies. Stroke 54 : 1246-1256, 2023.
 
19) Farhat HI, Elhammady MS, Ziayee H, et al : Eagle syndrome as a cause of transient ischemic attacks. J Neurosurg 110 : 90-93, 2009.
 
20) 宮田悠, 中原一郎, 太田剛史, ほか : 頸部内頸動脈解離による脳梗塞を繰り返した茎状突起過長症に対して急性期血行再建術と茎状突起摘出術を施行した1例. 脳卒中の外科 44 : 145-150, 2016.
 
21) Mori M, Yamamoto H, Koga M, et al : Hyoid bone compression-induced repetitive occlusion and recanalization of the internal carotid artery in a patient with ipsilateral brain and retinal ischemia. Arch Neurol 68 : 258-259, 2011.
 
22) Kinoshita N, Saito K, Tanaka T, et al : Swallowing-induced displacement of the carotid artery as a risk of stroke : Flip-flop phenomenon. Neurology 89 : 1643-1644, 2017.
 
23) Han CY, Long SM, Parikh NS, et al : Impingement of the Thyroid Cartilage on the Carotid Causing Clicking Larynx Syndrome and Stroke. Laryngoscope 132 : 1410-1413, 2022.
 
24) Bond KM, Krings T, Lanzino G, et al : Intracranial dissections : A pictorial review of pathophysiology, imaging features, and natural history. J Neuroradiol 48 : 176-188, 2021.
 
25) Mizutani T : Natural course of intracranial arterial dissections. J Neurosurg 114 : 1037-1044, 2011.
PubMed
26) Mizutani T, Kojima H, Asamoto S : Healing process for cerebral dissecting aneurysms presenting with subarachnoid hemorrhage. Neurosurgery 54 : 342-348, 2004.
 
27) Downer J, Nadarajah M, Briggs E, et al : The location of origin of spontaneous extracranial internal carotid artery dissection is adjacent to the skull base. J Med Imaging Radiat Oncol 58 : 408-414, 2014.
 
28) Arnold M, Bousser MG, Fahrni G, et al : Vertebral artery dissection : presenting findings and predictors of outcome. Stroke 37 : 2499-2503, 2006.
 
P.254 掲載の参考文献
1) Paciaroni M, Caso V, Agnelli G : Magnetic resonance imaging, magnetic resonance and catheter angiography for diagnosis of cervical artery dissection. In : Handbook on Cerebral Artery Dissection (ed by Baumgartner RW, Bogousslavsky J, Caso V, et al), p102-118, Karger AG, Basel, 2005.
 
2) Iwamoto T, Oyama N, Kitano T, et al : Spontaneous Dissection of Both Vertebral Arteries Diagnosed with Three-Dimensional T1-Weighted Image. J Stroke Cerebrovasc Dis 28 : e71-e72, 2019.
 
P.259 掲載の参考文献
1) 脳卒中治療ガイドライン 2021 (日本脳卒中学会脳卒中ガイドライン委員会編), p205-211, 協和企画, 2021.
 
2) Markus HS, Levi C, King A, et al : Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection : The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results. JAMA Neurol 76 : 657-664, 2019.
 
3) Daou B, Hammer C, Mouchtouris N, et al : Anticoagulation vs Antiplatelet Treatment in Patients with Carotid and Vertebral Artery Dissection : A Study of 370 Patients and Literature Review. Neurosurgery 80 : 368-379, 2017.
 
4) Georgiadis D, Caso V, Baumgartner RW : Acute therapy and prevention of stroke in spontaneous carotid dissection. Clin Exp Hypertens 28 : 365-370, 2006.
 
5) Lee VH, Brown RD Jr, Mandrekar JN, et al : Incidence and outcome of cervical artery dissection : a population-based study. Neurology 67 : 1809-1812, 2006.
 
6) Sacco RL, Adams R, Albers G, et al : Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack : a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke : co-sponsored by the Council on Cardiovascular Radiology and Intervention : the American Academy of Neurology affirms the value of this guideline. Circulation 113 : e409-e449, 2006.
 
7) Kernan WN, Ovbiagele B, Black HR, et al : Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45 : 2160-2236, 2014.
 
8) 小野純一, 平井伸治, 芹沢徹, ほか : 椎骨脳底動脈系解離性動脈病変の転帰決定因子 : 再出血に影響を及ぼす因子の検討. 脳神経外科ジャーナル 11 : 265-270, 2002.
 
9) 水谷徹, 有賀徹 : クモ膜下出血で発症した椎骨脳底動脈解離性動脈瘤における再出血の時期, 頻度と転帰-自験20例および文献48例の検討. 脳卒中の外科 22 : 389-393, 1994.
 
10) 柏原健一 : 脳動脈解離, もやもや病と脳卒中. 脳卒中データバンク 2021 (国循脳卒中データバンク2021編集委員会編), p58-61, 中山書店, 2021.
 
11) Carr K, Rincon F, Maltenfort M, et al : Incidence and morbidity of craniocervical arterial dissections in atraumatic subarachnoid hemorrhage patients who underwent aneurysmal repair. J Neurointerv Surg 7 : 728-733, 2015.
 
12) Endo H, Matsumoto Y, Kondo R, et al : Medullary infarction as a poor prognostic factor after internal coil trapping of a ruptured vertebral artery dissection. J Neurosurg 118 : 131-139, 2013.
 
13) Ahn JY, Han IB, Kim TG, et al : Endovascular treatment of intracranial vertebral artery dissections with stent placement or stent-assisted coiling. AJNR Am J Neuroradiol 27 : 1514-1520, 2006.
 
14) Yasui T, Komiyama M, Nishikawa M, et al : Subarachnoid hemorrhage from vertebral artery dissecting aneurysms involving the origin of the posteroinferior cerebellar artery : report of two cases and review of the literature. Neurosurgery 46 : 196-201, 2000.
 
15) 佐藤章, 本郷一博, 杉山達也, ほか : 内頸動脈「背側型」動脈瘤全国調査結果の解析-Part 2 : 出血例における治療を中心に- 脳卒中の外科 34 : 372-376, 2006.
 
P.265 掲載の参考文献
1) Takeda N, Komuro I : Genetic basis of hereditary thoracic aortic aneurysms and dissections. J Cardiol 74 : 136-143, 2019.
PubMed
2) 武田憲文 : 循環器病学の未来 : 胸部大動脈瘤・解離の遺伝子解析とゲノム医療. 医学のあゆみ 283 : 1223-1228, 2022.
 
3) Renard M, Francis C, Ghosh R, et al : Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. J Am Coll Cardiol 72 : 605-615, 2018.
 
4) 武田憲文 : 疾患Review-マルファン症候群. SRL宝函 40 : 21-30, 2019.
 
5) Loeys BL, Dietz HC, Braverman AC, et al : The revised Ghent nosology for the Marfan syndrome. J Med Genet 47 : 476-485, 2010.
PubMed
6) Takeda N, Hara H, Fujiwara T, et al : TGF-β Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections. Int J Mol Sci 19 : 2125, 2018.
 
7) Takeda N, Inuzuka R, Yagi H, et al : Clinical Impact of Copy Number Variation on the Genetic Diagnosis of Syndromic Aortopathies. Circ Genom Precis Med 14 : e003458, 2021.
 
8) Takeda N, Inuzuka R, Maemura S, et al : Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome. Circ Genom Precis Med 11 : e002058, 2018.
 
9) 日本循環器学会/日本心臓血管外科学会/日本胸部外科学会/日本血管外科学会. 2020年改訂版大動脈瘤・大動脈解離診療ガイドライン, 2020. [https://www.j-circ.or.jp/cms/wp-content/uploads/2020/07/JCS2020_Ogino.pdf] (2024年5月閲覧)
 
10) 犬塚亮 : 小児期におけるMarfan 症候群の診断・管理. 医学のあゆみ 264 : 217-222, 2018.
 
11) David TE, Park J, Tatangelo M, et al : Cardiovascular Events After Aortic Root Repair in Patients With Marfan Syndrome. J Am Coll Cardiol 82 : 1068-1076, 2023.
 
12) den Hartog AW, Franken R, Zwinderman AH, et al : The risk for type B aortic dissection in Marfan syndrome. J Am Coll Cardiol 65 : 246-254, 2015.
 
13) MacCarrick G, Black JH 3rd, Bowdin S, et al : Loeys-Dietz syndrome : a primer for diagnosis and management. Genet Med 16 : 576-587, 2014.
 
14) Seike Y, Matsuda H, Inoue Y, et al : The differences in surgical long-term outcomes between Marfan syndrome and Loeys-Dietz syndrome. J Thorac Cardiovasc Surg 164 : 16-25.e2, 2022.
 
15) 武田憲文 : 血管型エーラス・ダンロス症候群 ; 大動脈疾患. 別冊日本臨牀領域別症候群シリーズ No.6 循環器症候群 (第3版) II, p358-363, 日本臨牀社, 2019.
 
P.270 掲載の参考文献
1) 門間和夫 : 大動脈縮窄. 臨床発達心臓病学 [改訂3版] (高尾篤良, 門間和夫, 中澤誠, ほか編), p582-590, 中外医学社, 2001.
 
2) Prisant LM, Mawulawde K, Kapoor D, et al : Coarctation of the aorta : a secondary cause of hypertension. J Clin Hypertens (Greenwich) 6 : 347-350, 352, 2004.
 
3) Rengier F, Delles M, Eichhorn J, et al : Noninvasive 4D pressure difference mapping derived from 4D flow MRI in patients with repaired aortic coarctation : comparison with young healthy volunteers. Int J Cardiovasc Imaging 31 : 823-830, 2015.
 
4) Brown ML, Burkhart HM, Connolly HM, et al : Coarctation of the aorta : lifelong surveillance is mandatory following surgical repair. J Am Coll Cardiol 62 : 1020-1025, 2013.
 
5) Szopos M, Poussineau N, Maday Y, et al : Computational modeling of blood flow in the aorta-insights into eccentric dilatation of the ascending aorta after surgery for coarctation. J Thorac Cardiovasc Surg 148 : 1572-1582, 2014.
 
6) Massey R, Shore DF : Surgery for complex coarctation of the aorta. Int J Cardiol 97 (Suppl 1) : 67-73, 2004.
 
7) Nakamura E, Nakamura K, Furukawa K, et al : Selection of a Surgical Treatment Approach for Aortic Coarctation in Adolescents and Adults. Ann Thorac Cardiovasc Surg 24 : 97-102, 2018.
 
8) 福家愛, 西村和典, 毛原啓, ほか : 成人大動脈縮窄症. 胸部外科 68 : 502-505, 2015.
 
9) Carr JA, Amato JJ, Higgins RS : Long-term results of surgical coarctectomy in the adolescent and young adult with 18-year follow-up. Ann Thorac Surg 79 : 1950-1956, 2005.
 
10) Ovaert C, Benson LN, Nykanen D, et al : Transcatheter treatment of coarctation of the aorta : a review. Pediatr Cardiol 19 : 27-47, 1998.
 
11) Butera G, Manica JL, Marini D, et al : From bare to covered : 15-year single center experience and follow-up in trans-catheter stent implantation for aortic coarctation. Catheter Cardiovasc Interv 83 : 953-963, 2014.
 
12) Varma C, McLaughlin PR, Hermiller JB, et al : Coarctation of the aorta in an adult : problems of diagnosis and management. Chest 123 : 1749-1752, 2003.
 
13) Smith Maia MM, Cortes TM, Parga JR, et al : Evolutional aspects of children and adolescents with surgically corrected aortic coarctation : clinical, echocardiographic, and magnetic resonance image analysis of 113 patients. J Thorac Cardiovasc Surg 127 : 712-720, 2004.
 
14) 日本循環器学会. 成人先天性心疾患診療ガイドライン (2017年改訂版), p81-82, 2018. [https://www.j-circ.or.jp/cms/wp-content/uploads/2017/08/JCS2017_ichida_h.pdf] (2024年5月閲覧)
 
15) de Divitiis M, Pilla C, Kattenhorn M, et al : Vascular dysfunction after repair of coarctation of the aorta : impact of early surgery. Circulation 104 : I165-I170, 2001.
 
P.275 掲載の参考文献
1) Norgren L, Hiatt WR, Dormandy JA, et al ; TASC II Working Group : Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 (Suppl) : S5-67, 2007.
 
2) Bjorck M, Earnshaw JJ, Acosta S, et al : Editor's Choice-European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg 59 : 173-218, 2020.
 
3) Howard DP, Banerjee A, Fairhead JF, et al : Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events : Implications for Prevention. Circulation 132 : 1805-1815, 2015.
 
4) Creager MA, Kaufman JA, Conte MS : Clinical practice. Acute limb ischemia. N Engl J Med 366 : 2198-2206, 2012.
 
5) 日本血管外科学会データベース管理運営委員会, NCD血管外科データ解析チーム : 血管外科手術アニュアルレポート 2018年. 日本血管外科学会雑誌 31 : 217-237, 2022.
 
6) Fecteau SR, Darling RC 3rd, Roddy SP : Arterial thromboembolism. In : Vascular Surgery, 6th ed (ed by Rutherford RB), p971-986, Elsevier/Saunders, Philadelphia, 2005.
 
7) 笹嶋唯博 : 急性動脈閉塞の診療の実際. 心臓病診療プラクティス 17. 血管疾患を診る (高本眞一, 松尾汎編), p224-229, 文光堂, 1998.
 
8) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン, 2022. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年5月閲覧)
 
9) 古森公浩 : 腸間膜動脈血栓症 (急性・慢性). 新心臓血管外科テキスト (安達秀雄, 小野稔, 坂本喜三郎, ほか編), p722-727, 中外医学社, 2016.
 
10) Rutherford RB, Baker JD, Ernst C, et al : Recommended standards for reports dealing with lower extremity ischemia : revised version. J Vasc Surg 26 : 517-538, 1997.
 
11) 種本和雄 : MNMSとは何か. 心臓病診療プラクティス 17. 血管疾患を診る (高本眞一, 松尾汎編), p232-234, 文光堂, 1998.
 
P.282 掲載の参考文献
1) Bjorck M, Earnshaw JJ, Acosta S, et al : Editor's Choice-European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg 59 : 173-218, 2020.
 
2) 尾原秀明, 松原健太郎, 北川雄光 : 急性下肢虚血. 日本血管外科学会雑誌 27 : 109-114, 2018.
 
3) Umetsu M, Akamatsu D, Goto H, et al : Long-Term Outcomes of Acute Limb Ischemia : A Retrospective Analysis of 93 Consecutive Limbs. Ann Vasc Dis 12 : 347-353, 2019.
 
4) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン, 2022. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年5月閲覧)
 
5) Bjorck M, Koelemay M, Acosta S, et al : Editor's Choice-Management of the Diseases of Mesenteric Arteries and Veins : Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 53 : 460-510, 2017.
 
6) Tual A, Garzelli L, Nuzzo A, et al : Strengthening the Description of Superior Mesenteric Artery Occlusions in Acute Mesenteric Ischaemia : Proposition for an Anatomical Classification. Eur J Vasc Endovasc Surg 65 : 802-808, 2023.
 
7) 光部啓治郎, 赤坂伸之, 内田恒 : ステントグラフトおよび上腸間膜動脈逆行性ステント挿入にて救命し得た, 急性B型大動脈解離による腸管虚血の1例. 脈管学 55 : 147-151, 2015.
 
8) Lemma AN, Tolonen M, Vikatmaa P, et al : Choice of First Emergency Room Affects the Fate of Patients With Acute Mesenteric Ischaemia : The Importance of Referral Patterns and Triage. Eur J Vasc Endovasc Surg 57 : 842-849, 2019.
 
9) Blauw JTM, Metz FM, Nuzzo A, et al ; Dutch Mesenteric Ischaemia Study group : The Diagnostic Value of Biomarkers in Acute Mesenteric Ischaemia Is Insufficiently Substantiated : A Systematic Review. Eur J Vasc Endovasc Surg 67 : 554-569, 2024.
 
P.287 掲載の参考文献
1) Rutherford RB, Baker JD, Ernst C, et al : Recommended standards for reports dealing with lower extremity ischemia : revised version. J Vasc Surg 26 : 517-538, 1997.
 
2) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン, 2022. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年5月閲覧)
 
3) Bjorck M, Earnshaw JJ, Acosta S, et al : Editor's Choice-European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg 59 : 173-218, 2020.
 
4) Lipsitz EC, Veith FJ : Fluoroscopically assisted thromboembolectomy : should it be routine? Semin Vasc Surg 14 : 100-106, 2001.
 
5) de Donato G, Pasqui E, Ruffino MA, et al : Mechanical thrombectomy in acute limb ischemia : ad Interim results of the INDIAN UP Trial. J Cardiovasc Surg (Torino) 64 : 247-254, 2023.
 
6) Bjorck M, Acosta S, Lindberg F, et al : Revascularization of the superior mesenteric artery after acute thromboembolic occlusion. Br J Surg 89 : 923-927, 2002.
 
7) Beaulieu RJ, Arnaoutakis KD, Abularrage CJ, et al : Comparison of open and endovascular treatment of acute mesenteric ischemia. J Vasc Surg 59 : 159-164, 2014.
 
P.291 掲載の参考文献
1) Aboyans V, Ricco JB, Bartelink MEL, et al : Editor's Choice-2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 55 : 305-368, 2018.
 
2) Dao HH, Essalihi R, Bouvet C, et al : Evolution and modulation of age-related medial elastocalcinosis : impact on large artery stiffness and isolated systolic hypertension. Cardiovasc Res 66 : 307-317, 2005.
 
3) Soor GS, Vukin I, Leong SW, et al : Peripheral vascular disease : who gets it and why? A histomorphological analysis of 261 arterial segments from 58 cases. Pathology 40 : 385-391, 2008.
 
4) Mills JL Sr, Conte MS, Armstrong DG, et al : The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System : risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59 : 220-234.e342, 2014.
 
5) Conte MS, Bradbury AW, Kolh P, et al : Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 69 : 3S-125S.e40, 2019.
 
6) Kawarada O, Fujihara M, Higashimori A, et al : Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv 80 : 861-871, 2012.
 
7) Kawarada O, Yokoi Y, Higashimori A, et al : Impact of end-stage renal disease in patients with critical limb ischaemia undergoing infrapopliteal intervention. EuroIntervention 10 : 753-760, 2014.
 
P.297 掲載の参考文献
1) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン, 2022. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年5月閲覧)
 
2) Diehm C, Schuster A, Allenberg JR, et al : High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients : cross-sectional study. Atherosclerosis 172 : 95-105, 2004.
 
3) Grondal N, Sogaard R, Lindholt JS : Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65-74 years from a population screening study (VIVA trial). Br J Surg 102 : 902-906, 2015.
 
4) Newman AB, Shemanski L, Manolio TA, et al : Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19 : 538-545, 1999.
 
5) Sartipy F, Sigvant B, Lundin F, et al : Ten Year Mortality in Different Peripheral Arterial Disease Stages : A Population Based Observational Study on Outcome. Eur J Vasc Endovasc Surg 55 : 529-536, 2018.
 
6) Mills JL Sr, Conte MS, Armstrong DG, et al : The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System : risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59 : 220-34.e342, 2014.
 
7) 西上和宏 : 循環器疾患の検査 up to date 血管エコー. 日本臨床検査医学会誌 69 : 842-848, 2021.
 
8) Osborn LA, Vernon SM, Reynolds B, et al : Screening for subclavian artery stenosis in patients who are candidates for coronary bypass surgery. Catheter Cardiovasc Interv 56 : 162-165, 2002.
 
9) 北川孝道 : 超音波検査による血管内病変の検出. 天理医学紀要 19 : 99-104, 2016.
 
P.303 掲載の参考文献
1) Aboyans V, Ricco JB, Bartelink MEL, et al : Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 55 : 305-368, 2018.
 
2) Gerhard-Herman MD, Gornik HL, Barrett C, et al : 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease : Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 69 : 1465-1508, 2017.
 
3) Abola MTB, Golledge J, Miyata T, et al : Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease : A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee. J Atheroscler Thromb 27 : 809-907, 2020.
 
4) 日本循環器学会/日本血管外科学会. 2022年改訂版末梢動脈疾患ガイドライン, 2022. [https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Azuma.pdf] (2024年3月閲覧)
 
5) Conte MS, Bradbury AW, Kolh P, et al : Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg 58 : S1-S109.e33, 2019.
 
6) Sigvant B, Lundin F, Wahlberg E : The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected : A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease. Eur J Vasc Endovasc Surg 51 : 395-403, 2016.
 
7) Dormandy JA, Rutherford RB : Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31 : S1-S296, 2000.
 
8) Mills JL Sr, Conte MS, Armstrong DG, et al : The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System : risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59 : 220-34.e342, 2014.
 
9) 東信良, 重松邦広, 尾原秀明, ほか : 包括的高度慢性下肢虚血の診療に関するGlobal Vascular Guidelines ポケットガイド日本語訳版. 日本血管外科学会雑誌 30 : 141-162, 2021.
 
10) Miyata T, Mii S, Kumamaru H, et al : Risk prediction model for early outcomes of revascularization for chronic limb-threatening ischaemia. Br J Surg 108 : 941-950, 2021.
 
11) Farber A, Menard MT, Conte MS, et al : Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med 387 : 2305-2316, 2022.
 
12) Bradbury AW, Moakes CA, Popplewell M, et al : A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2) : an open-label, randomised, multicentre, phase 3 trial. Lancet 401 : 1798-1809, 2023.
 
13) 動脈硬化性疾患予防ガイドライン2022年版作成委員会 ; 岡村智教, 塚本和久, 荒井秀典, ほか : 動脈硬化性疾患予防ガイドライン [2022年版] (日本動脈硬化学会編), 日本動脈硬化学会, 2022. [https://www.j-athero.org/jp/wp-content/uploads/publications/pdf/GL2022_s/jas_gl2022_3_230210.pdf] (2024年3月閲覧)
 
14) Parikh SA, Schneider PA, Mullin CM, et al : Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures : an updated patient-level meta-analysis. Lancet 402 : 1848-1856, 2023.
 
15) Bonaca MP, Bauersachs RM, Anand SS, et al : Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med 382 : 1994-2004, 2020.
 
P.307 掲載の参考文献
1) De Maeseneer MG ; Thrombosis Guidelines Group of the Belgian on ; Thrombosis and Haemostasis ; Belgian Working Group on Angiology : Superficial thrombophlebitis of the lower limb : practical recommendations for diagnosis and treatment. Acta Chir Belg 105 : 145-147, 2005.
 
2) Leon L, Giannoukas AD, Dodd D, et al : Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 29 : 10-17, 2005.
 
3) Nasr H, Scriven JM : Superficial thrombophlebitis (superficial venous thrombosis). BMJ 350 : h2039, 2015.
 
4) Raffetto JD, Eberhardt RT : Benefit of anticoagulation for the treatment of lower extremity superficial venous thrombosis. J Vasc Surg Venous Lymphat Disord 3 : 236-241, 2015.
 
P.310 掲載の参考文献
1) 山下裕久 : 血栓性静脈炎 (表在性血栓性静脈炎・深部静脈血栓症). medicina 32 (増刊号 : Common Disease 200の治療戦略) : 98-99, 1995.
 
2) Di Minno MN, Ambrosino P, Ambrosini F, et al : Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis : a systematic review and meta-analysis. J Thromb Haemost 14 : 964-972, 2016.
 
3) Mangiafico M, Costanzo L : Superficial Venous Thrombosis : A Comprehensive Review. Healthcare (Basel) 12 : 500, 2024.
 
4) Marchiori A, Mosena L, Prandoni P : Superficial vein thrombosis : risk factors, diagnosis, and treatment. Semin Thromb Hemost 32 : 737-743, 2006.
 
5) Cosmi B : Management of superficial vein thrombosis. J Thromb Haemost 13 : 1175-1183, 2015.
 
6) Sartori M, Migliaccio L, Favaretto E, et al : D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis. Thromb Res 135 : 673-678, 2015.
 
7) Diez Vidal A, Gomez Lopez J, Rivera Nunez MA, et al : Risk factors and complications associated with superficial venous thrombosis. Eur J Intern Med 121 : 146-148, 2024.
 
8) Scott G, Mahdi AJ, Alikhan R : Superficial vein thrombosis : a current approach to management. Br J Haematol 168 : 639-645, 2015.
 
P.313 掲載の参考文献
1) Di Nisio M, Wichers IM, Middeldorp S : Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2 : CD004982, 2018.
 
2) Cannegieter SC, Horvath-Puho E, Schmidt M, et al : Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis : a nationwide cohort study. Blood 125 : 229-235, 2015.
 
3) Boehler K, Kittler H, Stolkovich S, et al : Therapeutic effect of compression stockings versus no compression on isolated superficial vein thrombosis of the legs : a randomized clinical trial. Eur J Vasc Endovasc Surg 48 : 465-471, 2014.
 
4) Nasr H, Scriven JM : Superficial thrombophlebitis (superficial venous thrombosis). BMJ 350 : h2039, 2015.
 
5) 広川雅之 : 下肢静脈瘤が痛くなった?! -血栓性静脈炎の治療. 下肢静脈瘤診療マニュアル, p173-181, 日本医事新報社, 2018.
 
6) Hingorani AP, Ascher E : Superficial venous thrombophlebitis. In : Handbook of Venous Disorders : Guidelines of the American Venous Forum, 3rd ed (ed by Gloviczki P), p314-319, Hodder Arnold, London, 2009.
 
7) Vilardell M, Sabat D, Arnaiz JA, et al : Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol 54 : 917-921, 1999.
 
8) Guex JJ : Thrombotic complications of varicose veins. A literature review of the role of superficial venous thrombosis. Dermatol Surg 22 : 378-382, 1996.
 
9) Decousus H, Prandoni P, Mismetti P, et al ; CALISTO Study Group : Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med 363 : 1222-1232, 2010.
 
10) Kearon C, Akl EA, Comerota AJ, et al : Antithrombotic therapy for VTE disease : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 : e419S-e496S, 2012.
 
11) Beyer-Westendorf J : Controversies in venous thromboembolism : to treat or not to treat superficial vein thrombosis. Hematology Am Soc Hematol Educ Program 2017 : 223-230, 2017.
 
12) Jorgensen CT, Brakkan SK, Forsund E, et al : Incidence of venous thromboembolism, recurrence, and bleeding after isolated superficial vein thrombosis : findings from the Venous Thrombosis Registry in Ostfold Hospital. J Thromb Haemost 22 : 526-533, 2024.
 
13) Lee AYY : When can we stop anticoagulation in patients with cancer-associated thrombosis? Hematology Am Soc Hematol Educ Program 2017 : 128-135, 2017.
 
14) Kearon C, Akl EA, Ornelas J, et al : Antithrombotic Therapy for VTE Disease : CHEST Guideline and Expert Panel Report. Chest 149 : 315-352, 2016.
 
15) Lozano FS, Almazan A : Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis : a prospective study. Vasc Endovascular Surg 37 : 415-420, 2003.
 
P.318 掲載の参考文献
1) 臨床医のための静脈血栓塞栓症 (深部静脈血栓症・急性肺塞栓症) 診断・治療マニュアル (福田幾夫 [責任編集], 田島廣之, 中村真潮, ほか編), p30-34, 医薬ジャーナル社, 2015.
 
2) Sato F, Kowatari R, Kondo N, et al : Two Surgical Patients with Paget-Schroetter Syndrome Presenting with Atypical Pathophysiology : Non-Effort Thrombosis. Ann Vasc Dis 12 : 83-86, 2019.
 
3) 日本循環器学会. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版), 2018. [https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf] (2024年5月閲覧)
 
4) 菅原基晃, 前田信治 : 血小板のレオロジー. 血液のレオロジーと血流, p62-67, コロナ社, 2003.
 
5) 荻原義人 : 深部静脈血栓症の治療と診断. 日本血栓止血学会誌 30 : 47-53, 2019.
 
P.325 掲載の参考文献
1) 日本循環器学会. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版), 2018. [https://www.j-circ.or.jp/cms/wp-content/uploads/2017/09/JCS2017_ito_h.pdf] (2024年5月閲覧)
 
2) Wells PS, Owen C, Doucette S, et al : Does this patient have deep vein thrombosis? JAMA 295 : 199-207, 2006.
 
3) Nybo M, Hvas AM : Age-adjusted D-dimer cut-off in the diagnostic strategy for deep vein thrombosis : a systematic review. Scand J Clin Lab Invest 77 : 568-573, 2017.
 
4) Kovac M, Mikovic Z, Rakicevic L, et al : The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Eur J Obstet Gynecol Reprod Biol 148 : 27-30, 2010.
 
5) van der Pol LM, Tromeur C, Bistervels IM, et al : Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med 380 : 1139-1149, 2019.
 
6) Metz AK, Diaz JA, Obi AT, et al : Venous Thrombosis and Post-Thrombotic Syndrome : From Novel Biomarkers to Biology. Methodist Debakey Cardiovasc J 14 : 173-181, 2018.
 
7) Vandy FC, Stabler C, Eliassen AM, et al : Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 1 : 117-1125, 2013.
 
8) Khorana AA, Kuderer NM, Culakova E, et al : Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111 : 4902-4907, 2008.
PubMed
9) Ay C, Dunkler D, Marosi C, et al : Prediction of venous thromboembolism in cancer patients. Blood 116 : 5377-5382, 2010.
 
10) Maufus M, Elias A, Barrellier MT, et al : Diagnosis of deep vein thrombosis recurrence : Ultrasound criteria. Thromb Res 161 : 78-83, 2018.
 
11) Rahaghi FN, Minhas JK, Heresi GA : Diagnosis of Deep Venous Thrombosis and Pulmonary Embolism : New Imaging Tools and Modalities. Clin Chest Med 39 : 493-504, 2018.
 
P.332 掲載の参考文献
1) Galanaud JP, Trujillo-Santos J, Bikdeli B, et al : Clinical Presentation and Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis. J Clin Oncol 42 : 529-537, 2024.
 
2) EINSTEIN-PE Investigators, Buller HR, Prins MH, Lensin AWA, et al : Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366 : 1287-1297, 2012.
 
3) EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, et al : Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363 : 2499-2510, 2010.
 
4) Yamada N, Hirayama A, Maeda H, et al : Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism-the J-EINSTEIN DVT and PE program. Thromb J 13 : 2, 2015.
 
5) Agnelli G, Buller HR, Cohen A, et al : Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369 : 799-808, 2013.
 
6) Nakamura M, Nishikawa M, Komuro I, et al : Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study). Circ J 79 : 1230-1236, 2015.
 
7) Hokusai-VTE Investigators, Buller HR, Decousus H, Grosso MA, et al : Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369 : 1406-1415, 2013.
 
P.336 掲載の参考文献
1) Kistner RL, Eklof B : Classification and etiology of chronic venous disease. In : Handbook of Venous Disorders : Guidelines of the American Venous Forum, 3rd ed (ed by Gloviczki P), p37-46, Hodder Arnold, London, 2009.
 
2) Lurie F, Passman M, Meisner M, et al : The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 8 : 342-352, 2020.
 
3) Sadick NS : Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 18 : 883-886, 1992.
 
4) Gundersen J, Hauge M : Hereditary factors in venous insufficiency. Angiology 20 : 346-355, 1969.
 
5) Cornu-Thenard A, Boivin P, Baud JM, et al : Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 20 : 318-326, 1994.
 
6) Rose SS, Ahmed A : Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg (Torino) 27 : 534-543, 1986.
 
7) Gandhi RH, Irizarry E, Nackman GB, et al : Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 18 : 814-820, 1993.
 
8) Clarke H, Smith SR, Vasdekis SN, et al : Role of venous elasticity in the development of varicose veins. Br J Surg 76 : 577-580, 1989.
 
9) Labropoulos N, Giannoukas AD, Delis K, et al : Where does venous reflux start? J Vasc Surg 26 : 736-742, 1997.
 
10) Raffetto JD, Khalil RA : Mechanisms of varicose vein formation : valve dysfunction and wall dilation. Phlebology 23 : 85-98, 2008.
 
11) Somers P, Knaapen M : The histopathology of varicose vein disease. Angiology 57 : 546-555, 2006.
 
12) Woodside KJ, Hu M, Burke A, et al : Morphologic characteristics of varicose veins : possible role of metalloproteinases. J Vasc Surg 38 : 162-169, 2003.
 
13) Rizzi A, Quaglio D, Vasquez G, et al : Effects of vasoactive agents in healthy and diseased human saphenous veins. J Vasc Surg 28 : 855-861, 1998.
 
P.341 掲載の参考文献
1) 白石恭史 : VI. 下肢静脈瘤の病態と治療 ; 1. 下肢静脈瘤の病態と疫学 ; D. 診断. 新臨床静脈学 (日本静脈学会編), p212-220, メジカルビュー社, 2019.
 
2) 白杉望 : 下肢静脈瘤. 臨床脈管学 (日本脈管学会編), p377-380, 日本医学出版, 2017.
 
3) Pavlovic MD, Schuller-Petrovic S, Pichot O, et al : Guidelines of the First International Consensus Conference on Endovenous Thermal Ablation for Varicose Vein Disease-ETAV Consensus Meeting 2012. Phlebology 30 : 257-273, 2015.
 
4) Eklof B, Perrin M, Delis KT, et al : Updated terminology of chronic venous disorders : the VEINTERM transatlantic interdisciplinary consensus document. J Vasc Surg 49 : 498-501, 2009.
 
5) 静脈エコー検討小委員会 ; 松尾汎, 佐戸川弘之, 小川智弘, ほか : 超音波による深部静脈血栓症・下肢静脈瘤の標準的評価法. 静脈学 29 : 363-394, 2018.
 
6) Lurie F, Passman M, Meisner M, et al : The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 8 : 342-352, 2020.
 
7) 小川智弘, 星野俊一 : エアープレチィスモグラフィ (空気脈波法). 脈管学 45 : 323-328, 2005.
 
8) Gloviczki P, Comerota AJ, Dalsing MC, et al : The care of patients with varicose veins and associated chronic venous diseases : clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 53 : 2S-48S, 2011.
 
9) 白杉望, 小畑貴司, 杉山悟, ほか : 下肢静脈瘤の超音波検査所見の標準的記載法. 静脈学 32 : 349-353, 2021.
 
10) 杉山悟, 松原進 : 超音波検査. 下肢静脈瘤診療実践ガイド-最新療法に基づく治療プラン (杉山悟, 松原進編著), p18-56, 診断と治療社, 2015.
 
11) 白杉望, 堀口定昭, 白土裕之, ほか : 下肢静脈瘤症例における無症候性深部静脈血栓症合併に関する検討 : 表在性血栓性静脈炎合併との関連について. 静脈学 25 : 13-19, 2014.
 
12) 鈴木修 : 下肢静脈瘤治療における非造影3DCT静脈撮影の有用性-特に術後再発に関する形態学的危険因子の検討-. 静脈学 27 : 267-273, 2016.
 
13) 春田直樹 : 下肢静脈瘤に対する治療法の変遷とその再発形式の特徴を考慮した治療法の現状. 日本血管外科学会雑誌 31 : 193-199, 2022.
 
14) De Maeseneer MG, Kakkos SK, Aherne T, et al : Editor's Choice-European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg 63 : 184-267, 2022.
 
15) Brake M, Lim CS, Shepherd AC, et al : Pathogenesis and etiology of recurrent varicose veins. J Vasc Surg 57 : 860-868, 2013.
 
P.347 掲載の参考文献
1) 松本孝一 : 一次性下肢静脈瘤の治療 ; 日常生活指導, 圧迫療法. 下肢静脈瘤ハンドブック-診断・治療の最前線- (下肢静脈瘤硬化療法研究会 ; 折井正博, 平井正文, 太田敬, ほか編), p149-155, 医歯薬出版, 2002.
 
2) 田代秀夫 : 今なぜあらためて硬化療法研究会なのでしょうか? Compression Sclerotherapy-私はこうしている-. 静脈学 34 : 383-387, 2023.
 
3) 孟真, 松原忍 : 圧迫療法の生理学と物理学. 新臨床静脈学 (日本静脈学会編), p126-132, メジカルビュー社, 2019.
 
4) 保田知生, 孟真 : 圧迫療法を理解する. 新弾性ストッキング・コンダクター [第2版増補版] 静脈疾患・リンパ浮腫における圧迫療法の基礎と臨床応用 (岩井武尚監, 孟真, 佐久田斉編), p66-106, へるす出版, 2020.
 
5) De Maeseneer MG, Kakkos SK, Aherne T, et al : Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg 63 : 184-267, 2022.
 
6) Rabe E, Breu FX, Cavezzi A, et al : European guidelines for sclerotherapy in chronic venous disorders. Phlebology 29 : 338-354, 2014.
 
7) 小川智弘 : 下肢静脈瘤に対する硬化療法について. 静脈学 34 : 375-381, 2023.
 
8) ETAの禁忌は何か? 下肢静脈瘤に対する血管内焼灼術のガイドライン 2019 (日本静脈学会監, 日本静脈学会ガイドライン委員会編), p51-56, 日本医事新報社, 2019.
 
9) 広川雅之, 佐戸川弘之, 八杉巧, ほか : 下肢静脈瘤に対するシアノアクリレート系接着材による血管内治療のガイドライン. 静脈学 31 : 141-152, 2020.
 
10) 日本血管外科学会データベース管理運営委員会, NCD血管外科データ解析チーム : 血管外科手術アニュアルレポート 2018年. 日本血管外科学会雑誌 31 : 217-237, 2022.
 
11) Lawrence PF, Alktaifi A, Rigberg D, et al : Endovenous ablation of incompetent perforating veins is effective treatment for recalcitrant venous ulcers. J Vasc Surg 54 : 737-742, 2011.
 
12) Muller R : [Treatment of varicose veins by ambulatory phlebectomy]. Phlebologie 19 : 277-279, 1966.
 
13) 宇藤純一, 塚本芳春 : 下肢静脈瘤血管内焼灼術の遠隔治療成績-日帰りストリッピング手術との比較-. 静脈学 32 : 105-110, 2021.
 
14) Wittens C, Davies AH, Bakgaard N, et al : Editor's Choice-Management of Chronic Venous Disease : Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 49 : 678-737, 2015.
 

書評

最近チェックした商品履歴

Loading...